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Abstract 
 
 The gammacoronavirus, Infectious Bronchitis Virus (IBV), is a respiratory pathogen of 
chickens. IBV is a constant threat to poultry production as established vaccines are often 
ineffective against emerging strains. This requires constant and rapid vaccine production 
by a process of viral attenuation by egg passage, but the essential forces leading to 
attenuation in the virus have not yet been characterised. Knowledge of these factors will 
lead to the development of more effective, rationally attenuated, live vaccines and 
reduction of the mortality and morbidity caused by this pathogen. 
 M41 CK strain was egg passaged four times many years ago at Houghton Poultry 
Research Station and stored as M41-CK EP4 (stock virus at The Pirbright Institute since 
1992). It was the first egg passage to have its genome pyrosequenced and was therefore 
used as the baseline reference. The overall aim of this project was to analyse deep 
sequence data obtained from four IBV isolates (called A, A1, C and D) each originating 
from the common M41-CK EP4 (ep4) and independently passaged multiple times in 
embryonated chicken eggs (figure 1.1). Highly polymorphic encoding regions of the IBV 
genome were then identified which are likely involved in the attenuation process through 
the formation of independent SNPs and/or SNP clusters. This was then used to direct 
targeted investigation of SNPs during the attenuation process of the four IBV passages. 
 A previously generated deep sequence dataset was used as a preliminary map of 
attenuation for one virulent strain of IBV. This investigation showed the nucleocapsid and 
spike as two highly polymorphic encoding regions within the IBV genome with the highest 
proportion of SNPs compared to encoding region size. This analysis then led to more 
focussed studies of the nucleocapsid and spike encoding region with the ultimate aim of 
mapping key attenuating regions and nucleotide positions.  
 The 454 pyrosequencing data and further investigation of nucleocapsid and spike 
encoding regions have identified the SNPs present at the same nucleotide positions within 
analysed A, A1, C and D isolates. These SNPs probably play a crucial role in viral 
attenuation and universal vaccine production but it is not clear if independent SNPs are 
also involved in loss of virulence. The majority of SNPs accumulated at different 
nucleotide positions without further continuation in Sanger sequenced egg passages 
presenting S2 subunit (spike) and nucleocapsid as polymorphic encoding regions which in 
nature remain highly conserved.
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1.1 Infectious Bronchitis Virus (IBV) and other avian pathogens 
 
 Research studies have revealed various pathogens to be responsible for initiation of 
respiratory diseases in poultry industry. A variety of viruses, bacteria and fungi might be 
involved in infection of the flock respiratory tract making them a significant component of 
the overall disease incidence in poultry (Glisson, 1998). Interestingly, many cases have 
shown bacteria as the defined primary component of respiratory disease such as infectious 
coryza and fowl cholera in chickens. In other cases, bacteria colonizing the respiratory 
tract, such as Escherichia coli, occur as secondary pathogens after viral involvement 
following Infectious Bronchitis virus infection (Page, 1961). Environmental factors were 
also proven to have an influence on respiratory disease in poultry. It is well known that 
disease severity is largely increased in the winter months characterised by low 
temperatures. The research studies have shown that chickens kept in lower temperatures 
(7-10 oC) are more susceptible to respiratory tract diseases rather than chickens maintained 
at higher temperatures (>24 oC). Other factors responsible for the large number of 
viral/bacterial infection in chickens are ventilation, humidity, atmospheric ammonia and 
the amount of dust in poultry shelters. (Kleven, 1998).  
 
 The viral diseases of the flock respiratory system have a huge impact in mortality across 
the poultry industry due to changes in viral antigenic properties such as Infectious 
Bronchitis Virus (IBV), an avian pathogen responsible for Infectious Bronchitis (IB) 
disease. This disease, characterised by respiratory distress, including nasal discharge, 
coughing and sneezing, results in reduced egg production and severe kidney damage 
leading to a high mortality rate (Selvarani, 2014). IBV is a Coronavirus, a single-stranded 
positive-sense enveloped RNA virus, discovered by Schalk and Hawn in 1931 (Schalk, 
1931), with a wide distribution in many parts of the globe. The most common strains are 
Arkansas, Connecticut and Massachusetts (North America), Q1 type (South America), 
Massachusetts-like type (Europe and Africa) and QX and Q1 IBV in Asia (reviewed by 
Jackwood, 2012). Although there are effective live attenuated vaccines for most strains, the 
immune response induced by a vaccine for one strain is often not effective against another 
strain. The SNPs, insertions and recombination in the IBV genome create serotype specific 
epitopes which vary between IBV strains, largely due to amino acid differences in the S1 
encoding region (reviewed by (Cook et al., 2012)). In addition, recombination in the S1 
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subunit of two IBV strains can also cause reduced vaccine protection (Jia et al., 1996). This 
was clearly illustrated in Sweden where Massachusetts-type vaccines did not protect 
against the Swedish IBV isolates present in the field. The subsequent investigation 
confirmed the emergence of a new IBV strain evolved from two Australian subgroups 
(Farsang et al., 2002). This N1/08 strain emerged directly from the recombination of S1 
subunit of Australian subgroup 2 (N1/88) and subgroup 1 (N1/03) (Hewson et al., 2014). 
This can make controlling outbreaks difficult, compounded by the fact that some IBV 
strains circulate together in small geographic regions and that the risk of infection also 
depends on the viral dose transmitted, virus strain, age of the chicks and many other 
environmental factors (Ignjatovic et al., 2002). However, research has shown partial IB 
disease control using the first accepted IBV live vaccines in the UK, H52 and H120 strains 
(Dutch field strain of IBV) (MacDonald and McMartin, 1976). Improvements in genetic 
and bioinformatics techniques combined with specific safety requirements for live IB 
vaccine production gives an opportunity for the design of a new universal live vaccine - 
genomic IBV clone (Geerligs et al., 2011, Zanaty, 2013). 
 
 Apart from IBV characterised with constant newly strands emerging, Infectious 
Laryngotracheitis virus (ILTV), Avian influenza virus (AIV) and Newcastle Disease virus 
(NDV) are also classified as the most common viral agents causing issues in the respiratory 
tract of birds (Villegas, 1998). Interestingly, ILTV was the first major avian pathogen ever 
found (1932) for which there has been sufficient vaccine development (reviewed by Bagust 
and Johnson, 1995). The respiratory disease is associated with haemorrhagic tracheitis, and 
expectoration of blood-stained mucus in young layers resulting in fast immune response of 
respiratory tract and very low mortalities (Ayala et al., 2014). In countries with modern 
intensive poultry industries, ILTV in layer flocks is no longer recognised as a cause of 
significant economic losses with single outbreaks occurring occasionally (Reddy et al., 
2014). However, research studies have confirmed several highly pathogenic strains of AIV 
resulting as fowl plague in the poultry industry (Keawcharoen et al., 2008). The highly 
virulent H5N1 type A AIV (Suarez et al., 1998) and its subtype H9N2 which possessed 
H5N1-like internal genomes caused a significant loss of layer fowl in Asia, Middle East, 
Europe and Africa (Guan et al., 2000). The subtype H7N7 of type A AIV caused severe 
respiratory disease in the poultry industry followed by diarrhoea, swollen heads and combs 
resulting in culling of large chicken population in Netherlands (Fouchier et al., 2004). In 
general NDV is much less pathogenic that AIV with a main division into Velogenic, 
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Viscerotropic and Neutropic strains (Bang, et al. 1974). Typically, the number of infected 
birds increases during the winter season compared to a very few cases analysed in summer 
time (Wajid et al., 2015). Interestingly, Velogenic and Neutropic types were not isolated in 
USA for many years but reported across Europe, Africa, Asia, Australia and South 
America (Shittu et al., 2016).  
 
1.2 Structure and replication of airborne avian pathogens 
 
The replication of avian airborne pathogens has a significant impact on disease progression 
in epithelial cells of the respiratory tract. IBV is a single stranded virus with a 27.6 kb 
RNA genome which exploits multiple host proteins to achieve successful cell entry. In fact 
all RNA viruses consist of only a small number of encoding regions so the investigation of 
them plays a crucial role in understanding the mechanisms responsible for the virus 
replication cycle inside the host cell, egress and immune evasion (Smith and Denison, 
2012, Kong et al., 2010).  
 
 
Figure 1.1. The picture presents: A= the image of IBV particles under the microscope,  B= 
the general structure of IBV including spike protein (S), envelope protein (E), membrane 
protein (M) and nucleocapsid (N) with RNA genome inside (Unknown photographer, 
2016). 
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 The figure 1.1 (Unknown photographer, 2016) shows that an IBV particle is comprised of 
four structural proteins; the spike (S), membrane (M) and small envelope (E) proteins are 
present in the viral membrane which surrounds the phosphorylated nucleocapsid protein 
(N) which interacts with the IBV genomic RNA (Fan et al., 2005). In addition, IBV also 
encodes accessory proteins; 3a, 3b, 4b, 5a and 5b with unknown function and two large 
open reading frames encoding proteins called Replicase 1a and 1b (figure 1.2). IBV 
assembly is based on association of the nucleocapsid with the M protein and structural 
proteins at the ER-Golgi intermediate region (ERGIC) (Klumperman et al., 1994). The 
fully formed viral particles bud off from the Golgi apparatus and exit the cell via 
exocytosis (Tooze et al., 1987).  
 
 
Figure 1.2. Schematic drawing of IBV genome including all gene sizes expressed in base 
pairs (bp). Picture includes shorter names of genes as follow: 3a= 3a protein, 3b=3b 
protein, E=envelope protein, M=membrane protein, 5a=5a protein, 5b= 5b protein and 
N=nucleocapsid. 
 
 The diameter of the virus particle is approximately 120nm combined with 20nm 
glycosylated spike (S) proteins which form large surface projections. The S glycoprotein is 
constructed with two subunits called amino-terminal S1 and carboxyl terminal S2. The S 
glycoproteins are assembled with the M proteins into the virion membranes through non-
covalent interactions and determine the ability of the virus to attach to the host cells 
(McBride and Machamer, 2010). The mechanism of viral membrane fusion to the host cell 
membrane suggests that the specific structure of the S1 subunit spike protein induces 
substantial changes in the S glycoprotein, allowing the nucleocapsid to be released into the 
cytoplasm (Tay et al., 2012, Wicht et al., 2014). As the S1 subunit of glycoprotein is 
responsible for binding to the host receptor, any SNPs in nucleotide sequence might have 
an impact on virulence, tissue tropism and persistence in a host (Luo and Weiss, 1998, 
Koch et al., 1990). 
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 Interestingly, IBV is not the only avian airborne pathogen having impact on disease 
progression in epithelial cells of the respiratory tract. A single stranded, negative sense, 
RNA Newcastle disease virus causes high mortality rates due to its fast cleavage of F 
protein responsible for the level of virulence and initiation of infection, followed by 
replication and spread of disease (Dortmans et al., 2010 and Dortmans et al., 2011). 
Interestingly NDVs have an influence on the impact of the disease caused by AIV which is 
also a single stranded, negative sense RNA virus. The AIV virulence and the severity of 
the disease in chickens is determined by the possible interactions and outcomes of 
infection (disease and virus shedding) when AIV and NDV co-infect bird populations in 
the farm (Costa-Hurtado et al., 2015 and Liu et al., 2015). One of the promising ideas is 
recognition of mechanisms responsible for of host-virus interactions to combat the virus 
(Reedy et al., 2014). Therefore, novel control strategies are urgently needed to limit 
outbreaks due to side effects of currently existing therapeutic strategies especially in the 
rural areas of developing countries.  
 
1.3 Outbreaks in poultry industry - failure of the vaccination programme  
 
 
 Acute respiratory tract infections caused by viral pathogens are the major reason of 
outbreaks in poultry industry especially in rural areas. The complex form of aetiology in 
respiratory diseases involves often more than one pathogen at the same time resulting in 
uncontrolled spread of an outbreak (Roussan et al., 2008). Interestingly, AIV, IBV, NDV 
and ILTV are classified as major respiratory pathogens because the outbreak can be caused 
by a viral agent in association with different strains of the same virus. Therefore acute 
respiratory infections are the leading cause of morbidity, mortality and economic loss in 
the poultry industry (Mounts et al., 1999). Similar to IBV strains constantly emerging, 
special attention should be paid to type A AIV known to be responsible for several 
outbreaks across the world. This avian pathogen causes high a mortality rate in the poultry 
industry due to its ability to cause infection with subtype H5 and H7 at this same time. The 
research studies revealed 12 outbreaks since 1959 (eight since 1990) caused by type A AIV 
in chickens (reviewed by Alexander, 2000) including the fowl plague in Netherlands in 
2003 (Koopmans et al., 2004).   
 
22 
 
 
 Modern live vaccines available against IBV and other avian pathogens present different 
level of cross protection. Therefore, difficulties in outbreak control were also reported 
among the poultry industry in Venezuela and China caused by genotype VII NDV. Further 
investigation has shown large genetic diversity within NDV isolates including 9 class 1 
NDV and 10 different lineages of class II NDV making the spread of avian disease even 
more difficult to stop. In addition, the efficiency of the vaccine protocols against present 
genotype VII virus in Venezuela and China was compromised by field-associated factors 
including immunosuppression. A large numbers of subtypes were also reported during the 
outbreaks of ILTV in Australia during the period of three years (Perozo et al., 2012). The 
recent losses in the Australian poultry industry have shown that genetic differences in viral 
pathogens are responsible for significant mortality in domestic chickens (Lee et al., 2012). 
Four new classes were identified and added to already existing five subtypes of ILTV. The 
main outbreaks were localised in New South Wales and Victoria where the avian 
respiratory diseases could possibly be limited by prevention using a range of therapeutic 
strategies developed over decades (Blacker et al., 2011). The research outcomes have 
shown humoral immune response against viral pathogens as one of the major solutions 
across the poultry industry. In addition, antibody production is one of the principal 
protective strategies in the avian respiratory system against ILTV, AIV and IBV (Swayne, 
2009) such as production of antibodies against the functional surface glycoproteins (Capua 
and Alexander, 2008).  
 
 Another effective strategy of public health focuses on the combination of vaccination and 
non-pharmaceutical intervention solutions in order to maximise surveillance activities 
(Sambhara and Poland, 2010). The veterinary vaccine production has been available for 
more than 50 years. Nowadays, development of recombinant genetically engineered 
techniques provides an opportunity to develop more efficient vaccines against avian viral 
pathogens. Two major strategies were introduced for the production of viral vaccines 
including modified live attenuated virus (Moss, 1991) and the other employing chemically 
inactivated virus. The novel approaches such as protective immunogens available for many 
viral pathogens in a single vector were created against RNA viruses such as NDV and IBV 
using reverse genetics system (Huang et al., 2003).  A wide range of therapeutics strategies 
is available due to the constant development of veterinary medicine. However, in 
underdeveloped countries such as India, the impact of avian respiratory diseases causes a 
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significant loss to the poultry industry and requires more preventive steps in the case of 
outbreaks (reviewed by Dhama et al., 2013).  
 
 A series of IBV outbreaks amongst commercial poultry occurred in different rural parts of 
Argentina between 2001 and 2008. During these seven years, 20 serotypes of IBV were 
isolated and classified into three separate clusters with no relationship to vaccine serotypes, 
clearly showing the weakness of the Massachusetts serotype vaccination programme used 
during the outbreak in South America (Rimondi et al., 2009). In a separate outbreak in 
Thailand (January-June 2008), thirteen field isolates were investigated to determine their 
evolution and origin. The analyses indicated the presence of two IBV groups within Thai 
IBV isolates which evolved separately but were circulating together, risking the creation of 
more genetically complicated serotypes (Pohuang et al., 2009). A separate case of fast 
spreading IB disease caused by strain CK/CH/LDL/97I brought major economic losses in 
Iraq, Jordan and Saudi Arabia in 2011. This situation shows the failure of the vaccination 
programme and the first reported case of strain CK/CH/LDL/97I originating from Taiwan 
present in the Middle East. These examples of outbreaks clearly show poor effectiveness of 
vaccination programmes due to larger IBV diversity (Rimondi et al., 2009, Ababneh et al., 
2012).  
 
1.4 Vaccine development against IBV and other avian pathogens 
 
 
 Current vaccination programmes focus on induction of the low-virulent, live or inactivated 
vaccine in order to boost protective immunity and minimise the antagonistic response of 
epithelial cells in the respiratory tract (Kapczynski and King, 2005).  The danger of 
uncontrolled avian airborne viruses spreading can increase due to nature of tracheal 
epithelial cells which fully support AIV and NDV growth and reinfection in the respiratory 
system.  The available types of live and dead vaccine can possibly reduce shedding of the 
avian airborne pathogens, morbidity, mortality and transmissibility in infected areas (Hafez 
et al., 2010) but also decrease the risk of new strains emerging by reducing field strain 
replication and providing several weeks of protection with a single vaccination of the 
poultry population (Swayne, 2006). The systematic reduction of poultry loss is possible 
due to implementation of dry powder aerosol vaccine against viral pathogen. However, the 
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major development issue is the deposition pattern of nebulized microspheres in the airways 
of chickens of different ages. The dose of vaccine necessary for sufficient protection of a 
chicken strongly depends on selection of appropriately sized airborne microspheres and 
their potential to avoid deposition in air sacs, lungs or penetration into lower respiratory 
tract (Corbanie et al., 2006).  
 
 The available live vaccine against avian respiratory pathogens induced higher protection 
and has been used for over 50 years (Zaffuto et al., 2008). The development of live 
vaccination program was used against Turkey rhinotracheitis virus (TRTV) focusing on 30 
cycles of alternate passages in 9-day old chicken embryos. Interestingly, the TRTV was 
identified as still infective presenting only mild, transient respiratory signs with full 
protection developed after 21 days. The research studies suggested that this attenuated 
strain has potential for use as a vaccine (Cook and Ellis, 1990). The progress in genetics 
technology also allowed for more efficient design of live vaccine against newly emerging 
avian pathogens after identification of fourteen amino acid substitutions which might be 
responsible for replication and pathogenicity changes (Buynak and Hilleman, 1966). 
Moreover, further analyses has shown that pathogenic strain was partially attenuated after 
50 and 70 egg passages and was fully attenuated after 90 passages, giving mortality and 
morbidity rates and viral loads in inoculated birds (Sun, et al., 2014 and Enders, et al., 
1946).  
 
 Until recently, most IBV vaccines were based on live attenuated or killed vaccines derived 
from classical or variant serotypes. These vaccines were developed from strains originating 
from the USA such as M41, Ma5, Ark, and Conn and Netherlands, for example, H52, as 
well as European strains such as 793/B, CR88, and D274. Effective and economically 
viable vaccines against IBV are available such as recombinant infectious bronchitis virus 
(IBV) H120 vaccine strain, but multiple combinations of available vaccines are needed 
because the level of cross-protection against different IBV strains is insufficient (Yang et 
al., 2016). Poor cross-protection is the result of variation in a major surface protein of the 
virus (the spike (S) protein). Therefore, highly attenuated nephropathogenic IBV vaccine, 
K2 strain was introduced to provide significantly higher levels of protection against variant 
QXIBV compared with chickens vaccinated with H120 in China (Lim et al., 2011). New 
variant strains of IBV (currently over 50) with differences in the S protein appear regularly 
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in the field and, through analysis based on the sequence of the S protein, it is impossible to 
predict which vaccines will induce protection against the newly emerged viruses (Bande et 
al., 2015). Notably, changes in geographical distribution and tissue tropism have been 
observed in QX-like strains that initially emerged in China and spread to cause great 
economic loss to poultry farmers in a region of south-east Asia. Only elaborate and 
expensive testing in chickens elucidates which vaccine combination is needed to protect 
against a new strain of IBV (De Wit et al., 2011). The availability of a unique reverse 
genetics system for IBV has the potential to lead to the development of a new generation of 
live vaccines. Vaccination-challenge experiments with the same and with different viruses 
could possibly identify if there are different degrees of protection and also examine the 
causes of insufficient and unpredictable levels of cross-protection. However, so far no 
specific vaccine or combination of vaccines will protect against all IBV types, and the only 
sure way to determine if a vaccination program will work is to test it experimentally in 
chickens against the variant virus in question (Cook et al., 1999). 
 
 Deep Sequencing also called as Massive Parallel Sequencing has important applications to 
vaccine design against viral pathogens. The excellent example is NGS of the wild-type 
yellow fever virus strain Asibi presenting a  RNA virus quasi-species whereas the live 
attenuated 17D vaccine virus was identified with limited quasi-species, indicating the 
excellent safety record of the attenuated vaccine strain (Barrett, 2016). Unfortunately, live 
vaccine efficiency strongly depends on its ability to multiply in respiratory tract tissues and 
induce an immune response. Therefore, the crucial point is to identify polymorphisms in 
major surface protein of the virus (the spike (S) protein) responsible for the virus virulence 
using NGS technology. The danger with introduction of live vaccines is ultrastructural 
changes in tracheal epithelium cells such as hypertrophy of the goblet cells, deformation of 
cilia or even plaque of lysed cells (Mast et al., 2005).  Interestingly, the damage to 
epithelial cells is also noticed in the case of infection with IBV which invades avian upper 
and lower respiratory tracts facilitating secondary infection with E.coli in the trachea 
(Nakamura et al., 1996).  Therefore, the disease outbreak caused by a vaccine strain that 
has reverted to virulence in unvaccinated or immunocompromised chickens tends to cause 
a high mortality rate and unpredictable spreading of IBV (Pohjola et al., 2014).   
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1.5 Polymorphism – the key in live vaccine production 
 
 Currently live IBV vaccines are normally attenuated by multiple repeat passage of a 
virulent virus in specific pathogen free (SPF) embryonated chicken eggs (McKinley et al., 
2008). Spontaneous mutations also called Single Nucleotide Polymorphisms (SNPs) arise 
throughout the IBV genome some of which lead to attenuation of the virus. However, as a 
consequence of this method the attenuated viruses produced by this approach have only a 
few SNPs that are responsible for loss of virulence and these will differ between vaccine 
strains (Cook et al., 2010). Two major drawbacks of this method is that once the virus is 
used to inoculate chickens the mutations within the attenuated vaccine viruses may back-
mutate resulting in virulent virus, an undesirable consequence, or that as a consequence of 
multiple passage the immunogenicity of the attenuated virus will not result in adequate 
protection. Given the nature of these live attenuated vaccines, further passage must be kept 
to a minimum to prevent potential loss of immunogenicity. The stocks must be grown in 
SPF chicken eggs to prevent the introduction of other potential pathogens (Ladmana et al., 
2002).  
 
 The extracted pyrosequenced viral genome identified with the SNPs after multiple egg 
passages gave a brief overview of the highly polymorphic regions in IBV genome and 
helped to identify the polymorphic similarities and differences in viral genome of four egg 
isolates. Further investigation of previous egg passages by Sanger sequencing was required 
to determine and understand the process of SNP accumulation over the time.  In fact, 
compared to the virulent strains, an attenuated virus has only nine to eighteen SNPs at the 
consensus sequence level but their role in loss of virulence must be confirmed by further 
investigation to determine which SNPs in the IBV genome are responsible for virulence 
and/or immunogenicity (Britton et al., 2012). The reverse genetics system presents many 
advantages including stability of the recombinant vaccinia virus genome supported by 
efficient replication in tissue culture. The process mainly focuses on generating a 
recombinant IBV using full-length cDNA which is cloned into the vaccinia virus where in 
vitro assembly is not a necessary step. The main advantage of using the vaccinia virus as a 
vector is the ability to generate modifications in the IBV cDNA using homologous 
recombination. This particular method enables production of insertion and deletion 
sequences from the vaccinia virus (Casais et al., 2001, Britton et al., 2005). Because of 
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substantial non-synonymous SNPs in the IBV spike glycoprotein, a recombinant IBV was 
created using the genetically modified Beaudette strain containing the Beaudette spike 
encoding region (Beau-R) and the virulent M41 strain (BeauR-M41(S)) which was 
observed to cause minimal damage to the ciliated epithelium cells of the trachea (Hodgson 
et al., 2004). Increasing our knowledge of the factors that influence the infectious ability of 
IBV will lead to the development of more effective live vaccines and reduction of the 
mortality caused by pathogens on farms across the world (Lim et al., 2012).  During the 
last decade an increasing effectiveness of live vaccines was observed due to improvements 
in understanding the genetic modifications and genes responsible for IBV pathogenicity 
(Bourogâ, 2014). 
 
1.6 Questions addressed by the MSc of Virology by Research: 
 
 What are the highly polymorphic encoding regions of IBV? 
 The investigation of genotypic diversity between IBV strains is an essential step to 
understand the differences in genome structure. In this thesis, experiments focused on 
analysing four IBV isolates each subsequently passaged a further 106 times in 
embryonated chicken eggs. The SNPs produced after egg passage four (ep4) and 110 
(ep110) were identified using 454 pyrosequencing in order to determine the highly 
polymorphic encoding regions of the IBV genome. Traditional Sanger sequence data of 
IBV genome from the four independent egg isolates were also analysed to determine the 
pattern of SNPs among IBV genes (nucleocapsid and spike encoding region) during egg 
passage. The investigation of highly polymorphic encoding regions was based on 454 
pyrosequencing data and was combined with analyses of regular Sanger sequence data 
obtained from every 10 egg passages in order to detect SNP accumulation (figure 1.2). 
 
 Which of these regions are common or unique in the IBV genome within the 
four egg isolates? 
 A key to understanding the complicated process of attenuation involves comparing the 
four viral populations focusing on nucleotide sequences obtained from pyrosequenced ep4, 
ep110 and Sanger sequenced egg passages (ep10-100) in order to determine similarities 
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and differences between these IBV isolates. The analyses of viral pyrosequencing data 
obtained after multiple passages in embryonated chicken eggs were performed by using 
bioinformatics tools to create a map of polymorphic encoding regions in the IBV genome 
from the four egg isolates. These maps were then compared to investigate the possible 
appearance of independent SNPs and/or SNP clusters characterized as unique or common 
in IBV isolates.  
 
 When does the process of SNP accumulation occur in the viral genome during 
passage in embryonated chicken egg? 
 The analysis of 454 pyrosequencing data from the pathogenic ep4 of IBV subsequently 
passaged 106 times in embryonated eggs generated the first sequence data about possible 
IBV genome SNP accumulation due to the relaxation of immune pressure resulting in 
attenuation. The Sanger sequence data from previous egg passages was considered as 
principal information about accumulation and distribution of SNPs over time. This 
information allowed to determine the pattern and frequency of accumulated SNPs in 
particular those encoding regions of viral genome during the egg passages.  
 
1.7 The aim of MSc of Virology by Research 
 
The main aim of the project was to determine the polymorphism during the 110 egg 
passages and create a “map” of SNPs in investigated IBV isolates. Firstly, the generated 
deep sequence dataset (ep4 and ep110) was used to identify the interesting regions within 
the viral genome that accrue high frequency polymorphisms during the process of 
attenuation. Secondly, a Sanger sequenced data set was obtained from previous egg 
passages (ep10-100) to examine the contribution of Nucleocapsid and Spike protein to 
attenuation process. The analysed two data sets then led to more focused studies with the 
ultimate aim of investigation SNPs accumulation over the time and possibly, quantifying 
their effects in loss of viral pathogenicity.  
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             Figure 1.3.   The summary of A, A1, C and D isolates originating form common 
M41 CK EP4 strain (ep4), independently passaged multiple times in embryonated 
chicken egg. White = original viral genome, green = Pyrosequenced egg isolates, 
blue = Sanger sequenced egg isolates. 
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Chapter 2: Materials and Methods 
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2.1   Introduction  
 
 This chapter explains in detail the materials and methods used during the investigation of 
IBV SNP accumulation in egg passages. M41 CK strain was passaged four times at The 
Pirbright Institute many years ago (data unavailable). The existing egg passage four (ep4) 
of M41 CK strain was the starting inoculum (main stock virus) for the four isolate groups 
originating from ep4 and subsequently passaged additional 106 times in embryonated 
chicken eggs by Dr Sarah Keep (The Pirbright Institute) between February 2010 and 
September 2011 (data not published yet). 454 pyrosequencing was then used to determine 
highly active SNP regions of IBV genome in starting egg passage 4 (ep4) and egg passage 
110 (ep110) of each isolate. The importance in 454 pyrosequencing of ep4 and ep110 was 
the ability to sequence different DNA template separately in such a way that each sequence 
readout was linked to an initial single molecule DNA template which was amplified 
separately from other templates. This method was crucial for accurate identification the 
polymorphisms between ep4 and ep110. In the course of this investigation two encoding 
regions (nucleocapsid and spike) were detected with a high number of SNPs compared to 
the rest of the IBV genome. Further experiments focused on investigating SNPs in the 
nucleocapsid and spike encoding regions from Sanger sequenced egg passages using 
sequence analysis software. The main template for using Sanger sequencing was a pure 
cDNA sample (PCR amplified) with a primer binding site obtained after viral RNA 
extraction. The designed primer amplified a specific product which enables the sequence to 
be analysed by bioinformatics software. The outcomes of analysed IBV isolates sequence 
data from the nucleocapsid and spike encoding regions delivered principal information 
regarding the accumulation of SNPs over time. The data set collected after Sanger 
sequencing of each egg isolate every 10 egg passages gave a brief understanding of SNP 
appearance in the viral genome in the absence of immune pressure which in the future will 
be a foundation for deeper investigation of polymorphism in previous egg passages using 
454 pyrosequencing. Published methods are referred to where appropriate. The details of 
primer sequences used for amplification of IBV encoding regions are included in Appendix 
1.  
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2.2    Verification of viral attenuation in four egg isolates 
 
 The attenuation of four egg isolates was confirmed after infecting twelve 8-day old Rhode 
Island Red chickens administering  eye drops (ten doses) of isolates (A-ep110, A1-ep110, 
C-ep110 and D-ep110) and demonstrating a lack of post-infection clinical signs on days 3-
7. The four birds were culled on days 4 and 6 post-infection and ciliary activity and virus 
presence in trachea were assessed. The remaining birds were culled on day 7 post-infection 
and tissues harvested to check for virus presence. If during the period of observation, more 
than two chickens died from causes not attributable to the viral agent, the test would be 
repeated. These observations were made based on previous work confirming viral 
attenuation through chicken egg passages at Compton Laboratory (The Pirbright Institute) 
in April 2014. The viral attenuation was confirmed as no chicken showed clinical signs, in 
particular respiratory signs, and no chicken died from causes attributable to the egg 
passaged virus. 
 
2.3    Standard methods for DNA and RNA screening 
 
2.3.1   Viral RNA storage and primer design 
 
 The four ep4 isolates that came from embryonated chicken eggs were named A, A1, C and 
D. The RNA samples used to investigate the SNPs in IBV egg isolates were extracted from 
every 10 egg passages of each egg isolates using RNeasy Plus Mini Kit according to 
manual and stored in a freezer at -80 oC. The two sets of primers were designed based on 
Massachusetts strain M41 to investigate the best set of primers for encoding region 
amplification. The assay included using literature review and Primer3 website (Untergasser 
et al., 2012) to design the best primers for amplification of the spike (S1 subunit and S2 
subunit) and nucleocapsid encoding regions.  
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2.3.2   RNA concentration and complementary DNA synthesis (cDNA) 
 
 The assay was performed using a NanoDropTM 2000 UV-Vis Spectrophotometer to 
measure concentration of total RNA and also detect the level of purity using 1 µl of each 
sample.  The cDNA synthesis was performed according to the protocol (SuperscriptTM III 
Reverse Transcriptase) using RNA samples. The synthesis of the first strand of cDNA was 
followed by adding 1 µl of Random Primers (50-250 ng), 1 µl of 10 mM dNTP Mix (10 
mM each dATP, dGTP, dCTP and dTTP at neutral pH) and RNA sample (maximum of 11 
µl with concentration <5000 ng), heated up to 65 oC for 5 minutes and incubated on ice for 
at least one minute. The contents of the tube were collected and mixed with 4 µl of 5x 
First–Strand Buffer, 1 µl 0.1 M DDT, 1 µl water and 1 µl SuperscriptTM III RT (200 
units/µl). The contents were incubated at 25 oC for five minutes and 50 oC for 60 minutes. 
The final step was to inactivate the reaction by heating at 70 oC for 15 minutes. 
 
2.3.3 PCR optimisation 
 
 Taq (Thermus aquaticus) DNA polymerase (Invitrogen) was used to investigate the 
optimum PCR condition by determining the best annealing temperature for the previously 
designed primers. The reaction contained all Invitrogen reagents except primers: 5x Green 
GoTaq flexi buffer, 25 mM magnesium chloride, 10 mM each dNTP, 10 mM each primer, 
1 µl template (216 ng/µl) and 1.25 units Taq in a total volume of 25 µl. 
 
Table 2.1. The range of annealing temperatures used for the investigated amplicons. 
Amplicon Primer name Tm (oC) The annealing temperatures (oC) 
S1 subunit S1_forward 56.1 54, 57, 60, 63 
S1 subunit S1_reverse 58.7 54, 57, 60, 63 
S2 subunit part1 S2(p1)_forward 57.1 46, 48, 50, 52 
S2 subunit part1 S2(p1)_reverse 58.8 46, 48, 50, 52 
S2 subunit part2 S2(p2)_forward 72.3 62, 64, 66, 68, 70, 72 
S2 subunit part2 S2(p2)_reverse 71.2 62, 64, 66, 68, 70, 72 
Nucleocapsid N_forward 58.4 51, 54, 57, 60 
Nucleocapsid N_reverse 58.7 51, 54, 57, 60 
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According to the information collected about the structure of the oligonucleotides and their 
Tm, the best annealing temperature and PCR conditions were chosen for improved and 
successful amplification of the encoding regions of interest. The PCR reaction for 
encoding regions of interest was prepared by pre-denaturation for 4min at 94 oC, followed 
by 30 cycles of denaturation at 94 oC for 60 s, annealing at various temperatures (table 2.1) 
for 40 s and extension at 70 oC for 120 s. The final extension step was performed at 72  oC 
for 10 min followed by analysing the PCR products on 1.0 % agarose gel. 
 
2.3.4 Separation of PCR amplicons by agarose gel electrophoresis 
 
 Agarose gel electrophoresis was used to examine the ability of designed primers to 
correctly amplify the chosen encoding regions and to visualise amplicons. The separation 
of DNA fragments based on length was performed using a 1.0 % agarose gel made in1x 
TAE buffer. Syber Safe DNA Gel Stain (3.5 µl/1 g of LB agar) was added before the gel 
solidified. Gels were run for approximately 60 minutes at 85V then photographed under 
UV light. The Syber Safe Stain intercalated with the DNA to fluoresce and if necessary 
enabled bands to be cut out from the gel for purification. 
 
2.3.5 The analyses of the PCR products  
 
 PCR products were purified using GFX PCR, DNA and Gel Band Purification Kit or PCR 
product purification (Qiagen QIAquick Spin Handbook) according to the manual. During 
the assay, the elution step was performed by using water (30 µl per sample) to extract 
DNA seen as bands on the agarose gel image with the exception of the A isolate samples 
(ep10-50) where 50 µl of water was used. The concentration of extracted DNA (ng/ µl) and 
the level of contamination of samples were then measured using a NanodropTM. The 
amplified genome sequences (minimum 1 ng/µl/100base pair) from four isolates were sent 
for Sanger sequencing with the previously designed set of primers. The details of DNA 
concentration and level of sample purity are available in Appendices 10, 11 and 12.   
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2.3.6 Testing primers under specific conditions 
 
 The two samples with the highest concentration of DNA (minimum 1 ng/µl/100bp) were 
sent for Sanger sequencing with designed primers for each encoding region of interest. 
This step was required to test the ability of primers to amplify the IBV encoding regions in 
PCR condition provided by supplier (Source Bioscience). 
 
2.4  Methods for analysing Sanger sequencing data 
 
This part of the investigation used  Sanger Sequencing technology for better understanding 
of polymorphisms in previous egg passages (ep10-100) of each egg isolate (A, A1, C and 
D). In DNA sequencing the nucleotide sequence of DNA is determined and appropriate 
treatments are used to generate DNA fragments that end at the four bases: adenine (A), 
guanine (G), cytosine (C) and thymine (T). Then the fragments were subjected to 
polyacrylamide gel electrophoresis so that molecules with one nucleotide difference in 
length were separated on the gel (Sanger et al., 1977). 
 
2.4.1   Chromas Lite  
 
 In the first stage of investigation into the viral SNPs, raw Sanger sequence data from every 
10 egg passages of four isolates (A, A1, C and D) received from Source Bioscience was 
analysed using the bioinformatics program Chromas Lite (Li-Cor, 2014). The detection of 
SNPs in the sequence of interest was possible due to chromatograms presented in a form of 
visible but not overlapping picks indicating the presence of SNPs in the genome. The 
primers designed for amplification of specific encoding regions across the IBV genome 
were able to amplify nearly the whole encoding region presenting clear and visible 
chromatograms enabling independent SNPs to be easily spotted. However, sometimes the 
amplification process was disturbed by secondary or tertiary structures in the sequence of 
interest. Therefore, Sanger sequencing results were less effective leading to points in the 
nucleotide sequence where readings with Chromas Lite were stated as “N” (unknown 
nucleotide). Single errors in Sanger sequence reads were fixed by manual correction based 
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on personal judgment regarding the type of nucleotide present in specific genome 
positions. The last stage of analysing the Sanger sequence data with Chromas Lite focused 
on cutting, from the sequence, parts which were amplified but encoded other genes in IBV 
genome. The fully analysed Sanger sequence data was exported as a separate Fasta file for 
further investigation. 
 
2.4.2 BioEdit  
 
 BioEdit (Hall, 2013) was used to visualise the sequences to detect any SNPs in the viral 
genome. The investigation of these SNPs required a full genome sequence of IBV (ep4) 
which was used as a reference sequence in the egg passages of the four investigated 
isolates. The full genome sequence was aligned together with the encoding region of 
interest and egg passage sequences amplified with the set of designed primers using 
BioEdit. This step played a crucial role in investigating the SNPs as the SNPs could be 
easily detected in the Sanger sequence data and identified at specific nucleotide positions 
by comparison with the full IBV genome. 
 
2.4.3 Excel – 454 Pyrosequencing and Sanger sequencing data sets 
 
 The list of SNPs detected in the Sanger sequence data was saved as excel file for each egg 
isolate (Microsoft Corporation, 2010). The table was organised for easy reading of the 
information relating to SNPs detected in S1 subunit, S2 subunit (part 1) and nucleocapsid 
encoding regions. Each file consisted of the reference sequence (ep4) and SNPs after every 
10 egg passages including nucleotide genome position, details of SNP, frequency in the 
case of ep4 and ep110 and also mutation type specification (Non-synonymous/ 
Synonymous). The identification of SNPs was done by comparison to the outcomes of 454 
pyrosequencing in each egg isolates (ep110).  
 
 However, a second set of data had to be generated due to large amount of SNPs in 
investigated sequences which could not be previously detected in 454 pyrosequencing data. 
Therefore, each isolate and its egg passages consist of two sets of SNP tables relating to 
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each genome of interest. Similar to the 454 pyrosequencing data, information generated by 
Sanger sequencing includes the reference sequence (ep4) and SNPs after every 10 egg 
passages including nucleotide genome position, details of SNP but without the frequency 
in the case of ep4 and also no mutation type specification. 
 
2.5 The 454 pyrosequencing analyses 
 
 The IBV isolate at ep4 as well as the four IBV isolates at ep110 (A ep110, A1 ep110, C 
ep110 and D ep110) were sequenced at the Liverpool Centre for Genomic Research 
(University of Liverpool) using 454 Pyrosequencing (Titanium chemistry, Roche). The 454 
data was generated by universal library preparation for each sample and through emulsion-
based clonal amplification of the DNA library fragments were put onto micron-sized 
beads.  As a result of the amplification of the DNA fragments reads were filtered out 
during sequencing signal processing and mapped to the closest reference genome (M41-
give accession number DQ834384) using Burrows–Wheeler Aligner (BWA) (Li and 
Durbin, 2009). The percentage gene coverage was calculated using the bedtools package 
(Quinlan and Hall, 2010). Single nucleotide polymorphisms (SNPs) and indels were then 
called using the varscan2 software package (Koboldt, et al., 2012). 
 
 The analysed and mapped 454 pyrosequencing data was used to investigate SNP 
appearance in the IBV genome. It was possible to establish the number and SNP frequency 
in ep110 (A, A1, C and D isolate) after 106 egg passages by performing a series of 
simulations generated from reference egg passage (ep4) and comparison to its genome 
sequence. The information obtained from the 454 pyrosequencing data showed the map of 
SNPs across the genome of four isolates (A, A1, C and D), identified the independent 
SNPs and/or SNP clusters, calculated the frequency and helped make a decision about 
further analysis of the spike (S1 subunit, S2 subunit) and nucleocapsid encoding regions.  
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Chapter 3: Results 
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3.1   Introduction  
 
 This chapter explains the results obtained during the investigation of primer design, 
amplification, 454 pyrosequencing in ep4 and ep110 but also the Sanger sequencing of 
spike and nucleocapsid. These two encoding regions were used during the investigation of 
independent SNPs and SNP clusters (defined as the group of a minimum three SNPs within 
the IBV genome which are close to each other (<50 bp) and separated by the gap of 100 bp 
from the nearest SNP) in egg passages (ep10-100) of four egg isolates. The SNP frequency 
was calculated after performing a series of simulations generated from reference sequence 
of ep4.  In addition, the reporting threshold of 5% was established due a high possibility of 
SNP error rate and >50% as the mark of SNP at consensus sequence level in 454 
pyrosequencing data set. The appendices 2-5 include details of gel images relating to the 
investigation into the best annealing temperature for the designed set of primers. The gel 
images showing the amplification process of investigated spike and nucleocapsid encoding 
regions are included in appendices 6-8. Appendices 9-12 presented in a form of the tables 
relating to NanodropTM measurements of RNA/DNA concentration and the purity of 
extracted and amplified IBV encoding regions. The additional SNPs identified in 
nucleocapsid encoding region of C isolate are presented in appendix 13. The table of 
IUPAC Ambiguity Codes used for identification minor SNPs are included in appendix 14.  
 
3.2   The 454 pyrosequencing of four egg isolates after 110 egg passages 
 
3.2.1 Polymorphism observed across each egg isolate 
 
Figure 3.1 presents the total number of SNPs at > 5 % and >50 % frequency in each isolate 
across the whole IBV genome, with the highest number of SNPs detected in A isolate (45) 
and the lowest in A1 isolate (36). In addition, the bar chart also clearly indicates the low 
number of >50 % SNP frequency (consensus level) found within egg isolates compared to 
much higher number of >5 % SNP frequency, as expected. The numbers of >50 % SNP 
frequency varies from the highest number of 18 SNPs in A isolate to the lowest of nine 
SNPs in C isolate. Interestingly, C isolate has shown the highest number of SNPs (36) at 
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>5 % frequency presenting the lowest number of mutations (nine) at >50 % frequency. 
This observation might indicate that the process of attenuation is possible with only nine 
consensus SNPs, so shows that not many consensus level SNPs are needed to eliminate the 
virulence in egg isolates.  
 
 
 Figure 3.1. The total number of SNPs after 110 egg passages for each egg isolate with 
frequency >5 % marked as blue and >50 % marked as red colour bar.  
 
 The results showed a high accumulation of SNPs in the spike and nucleocapsid encoding 
regions at the low SNP frequency (>5 %) but also an increased SNPs accumulation with 
high frequency (>50 %) compared to the rest of the IBV encoding regions. Furthermore, 
the investigation of SNPs in the spike encoding region has shown S2 subunit to be more 
polymorphic than the S1 subunit. Moreover, figure 3.1 suggests that the attenuation 
process might be caused by as low as nine SNPs at consensus sequence level in the 
quasispecies due to the low number of SNPs with frequency >50 % observed in each egg 
isolate compared to the number of SNPs identified with >5 % frequency.  
 
 
 
 
31
22
36
27
18
14
9
13
A isolate A1 isolate C isolate D isolate
Polymorphism observed across each egg isolate
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Table 3.1. The table includes the number of mutations with >5 % frequency observed in 
each gene of each isolate, the total number of mutations observed in the gene  and amount 
of SNPs overlapping within egg isolates in particular gene. SNPs observed in two or more 
samples were counted only once in each case. 
The SNPs with >5 % freq.  identified in genes of each egg isolate including shared 
mutations. 
        Isolates 
 
Gene 
A A1    C 
 
D  Total Observed 
in one 
isolate 
Observed 
in two 
isolates 
Observed 
in three 
isolates 
Observed 
in four 
isolates 
Replicase 1a 6 11 15 10 42 34 4 0 0 
Replicase 1b 5 3 7 5 20 16 2 0 0 
Spike  5 2 4 4 15 6 3 1 0 
3a  0 0 0 0 0 0 0 0 0 
3b  0 0 0 0 0 0 0 0 0 
E  0 0 2 0 0 0 0 0 0 
M  1 0 2 0 3 3 0 0 0 
5a  2 0 0 0 2 2 0 0 0 
5b  1 2 0 0 3 3 0 0 0 
Nucleocapsid 11 4 6 8 29 15 0 2 2 
 
 
The full details of shared SNPs identified within single gene of egg isolates were included 
in table 3.1 (>5 % freq.) and table 3.2 (>50 % freq.). The analysis of 454 pyrosequencing 
data clearly indicated the presence of unique and common SNPs at >5 % frequency shared 
between the egg isolates in ep110 (table 3.1). The highest polymorphism unique for each 
gene was identified within replicase 1a (34 SNPs), replicase 1b (16 SNPs) and 
nucleocapsid encoding region (15 SNPs). Moreover, analysis of the deep sequenced 
dataset also indicated unique polymorphisms for egg isolates in spike (six SNPs), M and 
5b (three SNPs) and 5a encoding region (two SNPs). Interestingly, the phenomenon of 
SNPs appearance at the same nucleotide position in more than one egg isolate were 
observed in encoding regions of nucleocapsid with appearance of two SNPs within three 
and four egg isolates at >5 % frequency. Further investigation of the deep sequenced data 
has also shown spike encoding region with three SNPs observed across two egg isolates 
and one SNP identified within three egg isolates. Furthermore, the polymorphisms present 
identified mutations in replicase 1a (four SNPs) and replicase 1b (two SNPs) shared within 
two egg isolates. Further investigation clearly shows lack of any common SNPs within the 
egg isolates in encoding regions of E, M, 5a and 5b,  encoding regions previously 
identified with a small number of unique mutation in ep110 of A, A1 and C isolate. 
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   Table 3.2. The table includes number of mutations with >50 % frequency observed in 
each gene of each isolate, the total number of mutations observed in the gene  and number 
of SNPs overlapping within egg isolates in particular gene. SNPs observed in two or more 
samples were counted only once in each case. 
The SNPs with >50 % freq. identified in genes of each egg isolate including shared 
mutations. 
         Isolates 
Gene 
A A1    C 
 
D  Total Observed 
in one 
isolate 
Observed 
in two 
isolates 
Observed 
in three 
isolates 
Observed 
in four 
isolates 
Replicase 1a 7 10 4 5 26 22 2 0 0 
Replicase 1b 1 2 1 1 5 4 1 0 0 
Spike  4 2 3 4 13 4 3 1 0 
3a  0 0 0 0 0 0 0 0 0 
3b  0 0 0 0 0 0 0 0 0 
E  0 0 0 0 0 0 0 0 0 
M  0 0 0 0 0 0 0 0 0 
5a  0 0 0 0 0 0 0 0 0 
5b  2 0 0 0 2 2 0 0 0 
Nucleocapsid 4 0 1 3 8 8 0 0 0 
 
 
 Furthermore, analysed pyrosequencing data with >50 % frequency in ep110 shows 
reduction of mutations in all investigated encoding regions (table 3.2). The deep sequenced 
dataset clearly shows the highest number of unique SNPs identified in replicase 1a (22 
SNPs) and nucleocapsid (eight SNPs), within replicase 1b and spike encoding regions 
(four SNPs) and also 5b encoding region (two SNPs). Interestingly, further investigation of 
shared mutations confirmed the presence of SNPs at consensus sequence level within three 
(one SNP) and two egg isolates (three SNPs) in spike at >50 % frequency rate in ep110. In 
addition, 454 pyrosequencing data presents the shared SNPs at >50 % frequency rate 
within two egg isolates in replicase 1a (two SNPs), replicase 1b (one SNP) but lack of any 
polymorphism in 3a, 3b, E, M, 5a, 5b and nucleocapsid encoding region within more than 
one egg isolate. Interestingly, spike was identified with the highest number of shared SNPs 
within the deep sequenced dataset at >50 % frequency, where nucleocapsid encoding 
region shared mutations within four egg isolates only at >5 % frequency. Therefore, both 
genes could be the potential keys encoding regions in a process of attenuation. 
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3.2.2 The most variable regions of IBV genome 
 
 Analysis of the deep sequence data identified four IBV encoding regions that had a larger 
number of SNPs than the other encoding regions of IBV genome including replicase 1a, 
replicase 1b, spike and nucleocapsid. Each egg isolate (A, A1, C and D) was treated 
individually focusing on pyrosequencing datasets to calculate the total number of 
synonymous and non-synonymous mutations in different genes after equal coverage was 
applied to analysed genomic regions and isolates. The shared SNPs identified in encoding 
region of more than one egg isolate were counted for each egg isolate separately and 
presented together with total number of SNPs above a frequency of 5 % in figure 3.2.    
The generated data shows a substantial number of SNPs established on the level of 30 non-
synonymous (NS) SNPs (2.3/1000 bp) and 12 synonymous (S) SNPs (0.9/1000 bp) in 
replicase 1a encoding region and high number of 13 NS (11/1000 bp) and 16 S (13/1000 
bp) in the nucleocapsid encoding region. The replicase 1b and spike encoding regions also 
showed increased number of SNPs with >5 % frequency compared to the rest of IBV 
encoding regions (replicase 1b: 12 NS at 1.5/1000 bp and 8 S at 1/1000 bp and spike 8 NS 
at 2.3 /1000 bp and 7 S at 2/1000 bp). The M, 5a and 5b encoding regions present a very 
low level of detected SNPs with maximum of two NS SNPs (8.0/1000 bp) in 5b and only 
one S SNP (4/1000 bp) in M encoding region. In addition, further analyses of deep 
sequenced data also showed that 3a, 3b and E encoding regions were identified with no 
SNPs relating to frequency greater than 5 %. 
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Figure 3.2. The total number of SNPs (non-synonymous and synonymous) with frequency 
>5 % (top) and >50 % (bottom) presented in different encoding regions of four egg 
isolates.  The SNPs were expressed in the form of two coloured bars: blue as non-
synonymous and red as synonymous SNPs per 1000 bp including absolute numbers of 
mutations in each encoding region. 
 
  The results of deep sequencing relating to SNP frequency >50 % (i.e. consensus level) 
showed the spike and nucleocapsid as two encoding regions with the highest number of 
SNPs with six NS SNPs, established as 1.7/1000 bp (spike) and seven NS SNPs at 
5.7/1000 bp (nucleocapsid). In addition, both encoding regions also presented synonymous 
SNPs identified as seven SNPs (2/1000 bp) in the spike and one SNP (0.8/1000 bp) in the 
nucleocapsid. The number of SNPs detected in replicase 1a was a little bit lower with the 
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increased SNP frequency of >50 % presenting as 18 SNPs at 1.4/1000 bp (NS) and eight 
SNPs at 0.6/1000 bp (S). The number of SNPs detected in replicase 1b was reduced and 
established as three SNPs at 0.4/1000 bp (NS) and two SNPs at 0.2/1000 bp (S). These 
data clearly shows the highest reduction of SNPs when increasing frequency from >5 % to 
>50 % was in replicase 1b (equally of 75 % reduction of NS and S) and nucleocapsid (56 
% reduction of NS and 94 % of S).  
 
3.2.3 Polymorphism identified in spike encoding region 
 
 
 Figure 3.3. The number of SNPs in the spike encoding region after 110 egg passages with 
frequency >5 %. The graph illustrates identified SNPs in the S1 subunit (blue) and the S2 
subunit (red) of spike protein encoding region in the four investigated egg isolates.   
When considering the size of each encoding region in IBV, the spike and nucleocapsid 
accumulate the most SNPs which might imply a role in viral attenuation of the investigated 
four egg isolates. Figure 3.3 shows the number of SNPs at >5 % frequency detected in the 
two subunits of the spike encoding region. The A isolate was identified with two SNPs in 
the S1 subunit comparing to three SNPs found in S2 subunit. Furthermore, also D isolate 
clearly presented a greater number of SNPs in the S2 subunit compared to S1 subunit. 
Interestingly A1 and C isolates have shown an equal number of SNPs shared between 
subunits of the spike encoding region. The results of deep sequenced data might be due to 
the smaller size of the S1 subunit (1607 bp) compared to the S2 subunit (1855 bp) 
enhancing lower number of mutations. However, this observation shows definitely a 
unique situation as the S2 subunit is more conserved than the S1 subunit in wild IBV 
strains.  
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3.2.4 Number of shared SNPs in spike encoding region 
  
 
Figure 3.4 The Venn diagram illustrates polymorphism in spike encoding region at >50 % 
frequency in ep110. The number of SNPs shared within the single, two, three and four egg 
isolates were included inside the coloured circles.   
 
 The further analyses of pyrosequencing data suggested that the spike encoding region 
plays a key role in the process of attenuation. The figure 3.4 presents the total number of 
shared mutations within four egg isolates. The S1 subunit has been identified with non-
synonymous mutation at nucleotide position 20720 in A, C and D isolate. S2 subunit has 
shown three synonymous SNPs at consensus sequence level (nucleotide position 22224 
and 22240) shared between C and D isolate and at nucleotide position 22421 in A and A1 
isolate. In addition, spike encoding region was also identified with four independent SNPs 
found only in a single egg isolate. The only one common > 50 % frequency SNP 
(nucleotide position 20720) in S1 subunit shared between three egg isolates might indicate 
the crucial role of unique SNPs at consensus sequence level but also minor SNPs in 
process of attenuation. Interestingly, S1 subunit known as highly polymorphic in wild IBV 
strains presents only one independent mutation (>50 % freq.) at nucleotide position 20429 
in C isolate. In addition, the S2 subunit was found with three independent SNPs at 
nucleotide positions 22285 and 22504 (A isolate) and nucleotide position 22459 (D 
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isolate). These data show that a few changes in the viral genome might play a significant 
role in the attenuation process of egg isolates.  
 
3.3   The preparation of samples for Sanger sequencing  
 
3.3.1    The concentration of RNA samples 
 
 
 The RNA concentration after extraction of viral samples varied from 1.2 ng/µl (A1-ep100) 
to 9.9 ng/µl (D-ep50). The measurements of 260/280 ratio were an acceptable level (1.8-
2.0) but 260/230 value presented in Appendix 9 is appreciably lower (<0.64) than expected 
(2.0-2.2) for non-contaminated nucleic acids suggesting the presence of contaminants such 
as carbohydrates, ethanol or guanidine isothiocyanate used for RNA isolation. 
 
3.3.2    The outcomes of primer design 
 
 The two sets of primers were designed for amplification of whole S1 encoding sequence 
with the forward primer (5`-TGA AAA ACT GAA CAA AAG ACA GA -3`) and the 
reverse primer (5`- GGG CAA CTT GTT ACA TTT TCA C -3`) based on information 
found in Zhu, et al., 2007. The second set of primers: forward primer (5`- GCT CTA GAA 
TGT TGG TAA CAC CTC TT -3`) and reverse primer (5`- CGG GAT CCT TAA TAA 
CTA ACA TAA GG -3`) were used according to Zhou, et al., 2003. The primer design for 
the S2 subunit was more complicated due to the larger size of the encoding region (approx. 
1800 bp). In this case the S2 subunit was divided into two separate but overlapping parts 
with two sets of primers for each encoding nucleotide sequence. The first part of the S2 
subunit (892 bp) was amplified with the first set of oligos: forward primer (5`- GGT GGT 
ATT ACT GCA GCT GGT GC-3`) and  reverse primer (5`- CTG ACC CTT TGT CAC 
AGT CTA GAC -3`) and second set of primers: forward primer (5`- ATG GTT TGC TTG 
TGT TGC CTC CC-3`) and reverse primer (5`- TTC CAG GAG CTA AGG GTA CAG 
CC -3`) designed on the Primer3 website. According to the information obtained from 
pyrosequenced ep4,  the design of primers for S2 subunit (part 2) encoding sequence was 
possible with the first set of forward primer  (5`- ATG GTT TTG CTT GTG TTG CCT -
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3`) and reverse primer  (5`- AGG AAG GAC GTG GGA CTT TG -3`) and the second set 
of primers: forward primer (5`- TGG TTT GCT TGT GTT GCC TC-3`) and reverse primer 
(5`-GGA AGG ACG TGG GAC TTT G -3`). The amplification of the nucleocapsid 
encoding region was successful due to two set of primers designed manually. The several 
basic rules of primer design were applied: primers were 18-24 nucleotides in length with a 
GC content of 40-60 % and an annealing temperature (Tm) >55 oC. The amplification 
assay was done with the first set of primers: forward primer (5`- CCA GGG GAA AAC 
TTG TGA GG -3`) and reverse primer (5`- TAC CGT TCG TTT CCA GGC TA -3`) and 
second set of primers: forward primer (5`- CCG CGT GTA CCT CTC TAG TA -3`) and 
reverse primer (5`- GGT CTA CCG TTC GGT TCC AG -3`). 
 
3.3.3    The identification the optimum annealing temperature of primers 
 
 
3.3.3.1   Spike encoding region (S1 subunit) 
 
 The primers for the S1 subunit were designed based on the information found in Zhu et 
al., 2007 and Zhou et al., 2003. The two sets of primers designed for amplification of the 
S1 subunit were tested at a different range of temperatures (51-67 oC) and investigated 
using gel electrophoresis with a 1 % agarose gel. The first set of primers failed to amplify 
the S1 subunit. The investigation of the second set of primers showed a very thin band 
appearing on the gel image with the appropriate size at a range of annealing temperatures 
between 54-63 oC. This observation led to the PCR and the gel electrophoresis being 
repeated for the second set of primers with a narrow range of annealing temperatures 
between 54-63 oC. According to the results presented in Appendix 2 the second set of 
primers was able to amplify the S1 subunit completely at an optimum annealing 
temperature of 57 oC, producing strong bands with the predicted PCR product size on the 
gel.  
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3.3.3.2    Spike encoding region (S2 subunit) 
 
 Both sets of primers were tested with the same range of temperatures (46-52 oC) due to 
similar melting temperature (57.1-58.8 oC) established using the Primer3 website. The 
appearance of bands with the correct bp size of product was observed in the cases of both 
primer sets. The amplification of the S2 subunit (part 1) was the most effective at an 
annealing temperature of 50 oC (the second set of primers) shown in Appendix 3. The 
primer design for amplification of S2 subunit (part2) was tested with a wide range of 
temperatures for more accurate investigation of the optimum annealing temperature 
demonstrating the most efficient amplification at 68 oC (the first set of primers) and failure 
of amplification process with the second set of primers (Appendix 4). 
 
3.3.3.3     Nucleocapsid encoding region  
 
 The successful amplification of the nucleocapsid encoding region was observed in the 
case of both primer sets (Appendix 5). The strongest bands were presented with the first set 
of primers in the range of temperatures between 51-60 oC. The second set of primers also 
amplified the correct IBV encoding region but the PCR product was less visible on the gel 
image at annealing temperatures of 51-60 oC. In addition gel bands at annealing 
temperature between 54-57 oC are visible but not as bright compared with the first set of 
primers. Therefore, the further amplification of nucleocapsid encoding region was 
continued with the first set of primers in annealing temperature of 57 oC. 
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3.4     Results of cDNA synthesis and amplification 
 
 
3.4.1   Introduction 
 
 
 This section shows in details the results of primers testing for spike and nucleocapsid 
encoding region. The investigation of the ability of the primers to amplify those encoding 
regions under specific conditions was necessary to investigate independent SNPs and SNP 
clusters in egg isolates. In addition, the spike encoding region was divided due to large bp 
size in three parts: S1, S2 (part 1) and S2 (part 2) subunits. The process of amplification 
spike and nucleocapsid focused on every 10 egg passages from ep10 to ep100 in each 
isolate. The gel images showing the amplified products are included in appendices 6-8. 
Appendices 9-12 included information related to NanodropTM measurements of RNA/DNA 
concentration and the purity of extracted and amplified IBV encoding regions.  
 
 
3.4.2    Testing primers under specific conditions 
 
The samples represent four encoding regions with relatively high DNA concentration 
ranging from 80.9 ng/µl (D isolate-ep50) to 29.5 ng/µl (A isolate-ep20). The 
contamination of samples after gel band purification was low shown by a 260/280 value at 
the level between 1.81(D isolate-ep80) and 2.39 (D isolate ep50) but 260/230 values were 
identified with a result much lower (<0.63) than expected 2.0-2.2 unit. 
 
Table 3.3 Summary of samples sent for test sequencing. 
Sample # Amplicon Isolate/Ep Conc. (ng/µl) 260/280 260/230 
1 S1 subunit A/20 29.5 1.97 0.16 
2 S1 subunit D/80 29.8 1.89 0.12 
3 S2 subunit (p1) A/20 39.9 1.99 0.41 
4 S2 subunit (p1) D/50 80.9 2.39 0.63 
5 S2 subunit (p2) A/20 19.4 2.32 0.03 
6 S2 subunit (p2) C/50 31.1 1.97 0.15 
7 Nucleocapsid D/40 34.7 1.82 0.28 
8 Nucleocapsid D/80 33.7 1.81 0.23 
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3.4.3    Spike encoding region - S1 subunit 
 
 The gel image presents very strong bands in every 10 egg passages of A isolate in ep10-50 
and less visible bands in ep60-100 (Appendix 6).  The A1 isolate showed only partial 
success of S1 subunit amplification with visible bands produced after ep60 to ep90. 
However, the C isolate was found with very effective amplification due to the size of the 
bands and their dark colour suggesting that the designed primers were able to amplify the 
gene from most egg passages excluding ep50 and ep100. The most efficient results of the 
amplification process were found with the D isolate which presented visible and strong 
bands in all egg passages except ep10. Furthermore, lack of visible bands representing 
non-specific products allowed for the second step focusing on purification of investigated 
isolates. Appendix 10 includes NanodropTM readings relating to the concentration and 
purity of amplified products, highlighting the highest concentration of DNA found with the 
D isolate ep70 (86.5ng/µl) and the lowest in A1 isolate ep80 (16.9 ng/µl).  The regular 
Sanger sequencing could be performed in all cases regarding to A, A1, C and D isolate 
where majority of PCR products ware successfully purified. The measurements of 260/280 
ratio was found to be at a satisfactory level (1.8) but 260/230 ratio for most of DNA 
samples presented in appendix 10 are lower (<1.72) than expected 2.0-2.2 unit indicating 
sample contamination with carbohydrates, ethanol or Guanidine HCL used for DNA 
isolation. 
 
3.4.4    Spike encoding region - S2 subunit (part 1) 
 
 The gel image of the cDNA S2 subunit (part 1) amplification (Appendix 7) showed partial 
success in the case of A and A1 isolate. The early ep10-50 of the A isolate and later ep60-
100 of A1 isolate were successfully amplified resulting in strong, visible bands. Low 
quality bands were found with A isolate ep60-100 and A1 isolate ep20-50 (ep10 of A1 
isolate was not involved in experiment due to low RNA concentration). The amplification 
of the C isolate egg passages was successful shown by the appearance of strong bands on 
the agarose gel. The complete amplification of the S2 subunit (part 1) was also observed in 
the D isolate where bands were presented in all investigated egg isolates except for ep10. 
The highest concentration of DNA was found with A isolate ep20 (50.4 ng/µl) and the 
lowest was in A1 isolate ep20 (8.9 ng/µl). Appendix 11 also indicates the values of 
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NanodropTM where 260/280 values were detected at a satisfactory level but 260/230 ratio 
was lower (<1.42) than expected level of 1.8-2.0 unit.  
 
3.4.5     Spike encoding region - S2 subunit (part 2) 
 
 The S2 subunit (part 2) was not amplified except for two samples which were sent for test 
Sanger sequencing (A isolate ep20 and C isolate ep50). However, the failure of the Sanger 
sequencing reads showed that primers cannot be used for further investigation. In addition, 
the information obtained for 454 pyrosequencing data suggested that the S2 subunit (part 
2) did not show high polymorphism presenting five SNPs at >5 % frequency and one SNP 
at >50 % frequency within four egg isolates. 
 
3.4.6    Nucleocapsid encoding region 
 
 The amplification of the nucleocapsid encoding region was performed with the first set of 
designed primers which presented the strongest ability to amplify this particular encoding 
region of the viral genome. The gel images in Appendix 8 confirmed that most of the egg 
passages from the four egg isolates could be further analysed for the detection of SNPs. 
The investigation showed amplification failure only in ep10 of the D isolate with no visible 
bands. According to the Appendix 12 the highest concentration of DNA was found with 
ep40 (45.7 ng/µl) and the lowest in ep20 (15.7 ng/µl) of the A1 isolate.  The measurements 
of 260/280 ratio was found in most of cases to be at a satisfactory level of 1.8-2.0 unit. 
However, a few samples of A, A1 and C isolate presented 260/280 values at >2.0 level 
which might indicate a problem with the regular Sanger sequencing reads.  In addition, 
260/230 values investigated with the NanodropTM measurements were lower (<0.84) than 
expected 2.0 unit (Appendix 12). 
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3.5    Outcomes of sequencing analysis 
 
3.5.1   Introduction  
 
 This section explains in detail the results obtained during the investigation of SNPs using 
Sanger sequencing (ep10-ep100) in spike and nucleocapsid encoding regions of four 
isolates (A, A1, C and D), with comparisons to the SNPs identified from the 454 
pyrosequencing data (ep4 and ep110). The analyses of 454 pyrosequencing data clearly 
showed lack of >50 % frequency SNPs shared between four isolates. However, S1 and S2 
subunit showed SNPs correlation within more than one isolate at consensus sequence level. 
Further investigation, presents numerous SNPs identified with Sanger sequencing as 
independent SNPs and/or SNP clusters within the egg isolates but also numerous SNPs (C 
or T residue) within egg passages of each isolate. The additional SNPs of C isolate were 
included in appendix 13. Appendix 14 presents the table used for identification of minor 
SNPs using regular Sanger sequencing method within egg passages. 
 
3.5.2    The SNP accumulation in S1 subunit 
 
 The investigation of SNPs in the S1 subunit detected with the 454 pyrosequencing data 
showed five SNPs found in the A isolate, four SNPs in the C and D isolate and one SNP in 
the A1 isolate. An interesting observation was made at nucleotide position 20720 where a 
non-synonymous SNP with a frequency of 99.5 % in ep110 was observed in the 
pyrosequencing data in the A, C and D isolates resulting in a change of amino acid 
sequence (lysine to arginine) as seen in table 3.4. However, the SNP accumulation in 
Sanger sequenced egg passages varies in each of the investigated egg isolates showing the  
A and C isolate with ambiguous SNPs (the ambiguity code R codes for A or G) in ep20-60 
which at some point were classified as SNP at consensus sequence level. Interestingly, 
high SNP frequency rate in D isolate presents consensus sequence SNPs in all Sanger 
sequenced samples (ep50-70 and ep90) clearly illustrating similarities in SNP 
accumulation within egg isolates presented with ~100 % SNP frequency in ep110.  
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Table 3.4. The SNPs found in more than one egg isolate with specification of mutation 
NS/S (Non-synonymous/Synonymous) indicated to the sequence of ep4. Table also 
includes the % SNP frequency for ep4 and ep110. White = not sequenced, yellow = failure 
of sequencing reads, orange = minor SNP, red = lack of SNP and green = SNP at 
consensus sequence level. 
The nucleotide position 20720 
 NS/S 
 
                Ep # 
Egg isolate 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq 
% 
NS A A 100   R  G      G 99 
NS C A 100  R  R  R  G G  G 99 
NS D A 100     G G G  G  G 100 
The nucleotide position 21630 
NS/S     Ep # 
Egg isolate 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq 
% 
S A T 100  C         C 1.7 
S C T 100           C 1.1 
S D T 100    C       C 1.1 
 
 
In addition, further investigation showed the appearance of a SNP in the viral genome 
when the SNP frequency in the ep110 pyrosequencing data reached only <1.7 % and could 
not be detected in ep4. Interestingly, this low frequency SNP was found within the A, C 
and D isolates at nucleotide position 21630 as one of the total five SNPs                                                                          
observed in spike encoding region of more than one egg isolate. The single consensus 
sequence SNP might explain the very low SNP frequency in ep110 by showing through 
Sanger sequenced egg passages the accumulation in ep20 without further appearance of 
SNP. The S1 subunit of the spike encoding region was identified only with two SNPs that 
were found in more egg isolates suggesting some SNPs correlation between the four 
investigated egg isolates. Furthermore, the ≥99 % SNP frequencies in ep110 might have an 
influence on the appearance of the greater number of SNPs in the Sanger sequence data 
from previous egg passages comparing to low SNP frequency (≤1.7%) mirroring little SNP 
activity in previous egg passages.  
 
 Further analyses of sequence data also detected a number of SNPs unique to the 
investigated isolates as seen in table 3.5. The A isolate was identified with three minor 
SNPs with the highest SNP frequency (14.8 %) estimated at nucleotide position 21543 in 
ep20 and ep110 causing a change from aspartate to glutamate in the amino acid sequence 
of the viral population. The A1 egg isolate showed only one unique SNP at nucleotide 
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position 20429 as ambiguous SNP (C or T nucleotide) detected in ep50-60 followed by 
change at consensus sequence level in ep80 and ep100 resulting in 100 % SNP frequency 
in ep110. Further analyses of the C and D isolate confirmed the presence of minor SNPs 
with a low       frequency (<1.2 %) in ep110 and no SNP accumulation in Sanger 
sequenced egg passages. Interestingly, the C isolate also presented a SNP at nucleotide 
positon 21489 with a frequency of 12.1 % in ep110 and a minor SNP in ep90. The number 
of unique SNPs (S1 subunit) presented in each egg isolate was found only in minor part of 
viral populations presented by a <15 % SNP frequency (except of A1 isolate). These data 
show that the frequency rate in ep110 depends on low SNP accumulation in previous egg 
passages investigated by regular Sanger sequencing.  
  
Table 3.5. The minor SNPs and consensus sequence SNPs identified in all screened egg 
passages unique for each egg isolate.  Specification of mutation NS/S (Non-
synonymous/Synonymous) was indicated to the sequence of ep4. White = not sequenced, 
yellow = failure of sequencing reads, orange = minor SNP, red = lack of SNP and green = 
SNP at consensus sequence level. 
A isolate 
 NS/S 
 
           Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
NS 21543 T 100  A         A 14.8 
S 21579 T 100           C 2.8 
S 21618 G 100           A 1 
A1 isolate 
NS/S Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
NS 20429 C 100     Y Y  T  T T 100 
C isolate 
NS/S Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
S 21489 T 100         W  A 12.1 
NS 21928 C 100           T 1.2 
D isolate 
NS/S Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
NS 20760 T 100           A 1.1 
S 20871 C 100           T 1.2 
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3.5.3    The additional SNPs activity in S1 subunit  
 
 Further investigation into Sanger sequenced egg passages of the analysed egg isolates 
detected a number of SNPs previously not identified in the 454 pyrosequencing data. The 
A isolate had a small number of SNPs presented with a random appearance across the 
investigated egg passages (table 3.6.). In fact there are two mutations that continue from 
ep30 to ep50 but the analyses of SNPs after ep50 was impossible due to failure of Sanger 
sequencing reads. Interestingly, the ep10 in the A isolate showed a unique SNPs cluster 
built up within an 84 bp encoding region. The nine SNPs at consensus sequence level were 
identified between nucleotide positions 20536 and 20620 without its further identification 
in later egg passages. Furthermore, deeper analyses have detected the T residue 
replacement by a C residue or vice versa accounted as 78 % of the total SNPs observed in 
SNP cluster of ep10 A isolate. Further investigation also identified two minor SNPs within 
the SNP cluster at the nucleotide position 20536 and 20595 in the A isolate (represented 
with ambiguity codes in Appendix 14). The further sequence analyses presented an 
appearance of SNP without further continuation in later egg passages but also independent 
SNPs visible in more than one egg passages. In addition, three closely related consensus 
sequence SNPs were identified in ep30 at nucleotide positions 21271, 21273 and 21309 
showing a formation of SNP cluster without continuation in further egg passages. 
However, there is an exception to previous example showing SNPs at nucleotide positions 
21838 and 21865 with visible continuation of SNPs in the nucleotide residues of ep30 and 
ep50. This SNP accumulation was closely investigated presenting a SNP cluster formed by 
mix of minor and consensus sequence SNPs within nucleotide position 21803 -21865 
found in ep50 of A isolate. However, the further observation was not possible due to 
failure of Sanger sequencing in ep60-100. These data have shown a major difference in 
accumulation of SNPs identified in early egg passages and/or in ep110. Considering the 
available Sanger sequence data, the additional SNPs previously not detected in ep110 
(deep sequenced data) were present in the early egg passages of A isolate but also in later 
egg passages of A1 isolate. 
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 Table 3.6. The Sanger sequencing outcomes of A and A1 isolate presenting independent 
SNPs and SNP clusters identified in S1 subunit after indicating to the sequence of ep4. 
White = not sequenced, yellow = failure of Sanger sequencing reads, orange = minor SNP, 
red = lack of SNP and green = SNP at consensus sequence level. 
A isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
20536 G R          
20554 T C          
20555 C T          
20558 C T          
20559 A C          
20595 T W          
20601 T C          
20610 T C          
20620 T C          
21271 G   A        
21273 G   A        
21309 G   A        
21323 A     G      
21803 A     M      
21832 A     M      
21838 A   T  T      
21865 G   A  A      
A1 isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
20399 T         G  
20400 G         A  
20429 C     Y  T    
20430 T         A  
20440 C         T  
20443 T         C  
20485 T         G  
20495 C         A  
20496 A         G  
20497 T         C  
20503 C       M    
20520 T         C  
20521 A         G  
20526 A         T  
20540 C         A  
20590 T         C  
20604 A         T  
20910 G     A      
20914 A     G      
20918 A     W      
20925 A     C      
20932 G     T      
20940 T     A      
20947 G     T      
20952 T     A      
21746 C       T    
21765 C       G    
21767 A       T    
21793 C       M    
21908 C       G    
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The failure of the Sanger sequencing reads between ep20-40 in A1 isolate prevented 
determination of the polymorphism in the early stages of egg passages (table 3.6). 
However, the investigation of ep50, ep70 and ep90 showed only one case of SNP 
continuation within the egg passages at nucleotide position 20429 with minor SNP (ep50) 
and change at consensus sequence level (ep70). Furthermore, the A1 isolate was also 
analysed in the light of SNP clusters showing the highly polymorphic encoding region 
(eight SNPs) between nucleotide positions 20910 and 20952 in ep50 separated by 480 bp 
from the nearest independent SNP. In addition, the confirmed SNP cluster presented more 
variable SNPs compared to the highly polymorphic encoding region identified in ep10 of 
the A isolate. The analyses of Sanger sequenced data showed that SNPs involving pairs of 
A or G and T or A residues accounted for 50 % in a SNP cluster (ep50 of the A1 isolate). 
In addition, this particular SNP accumulation was identified as being mostly SNPs at 
consensus sequence level with the exception of the nucleotide position 20918 shown as 
minor SNP (presented with ambiguity code).  Furthermore, ep70 presented a SNP cluster 
composed of five SNPs between nucleotide positions 21746 and 21793 with no additional 
polymorphic genomic positions within 115 bp. The SNP cluster (ep70) was identified in 75 
% as the consensus sequence SNPs with the exception to nucleotide position 21793 
defined as a minor SNP (found as IUPAC Ambiguity Code). Furthermore, the 
phenomenon of SNP cluster in the viral genome was confirmed in ep90 with 15 consensus 
sequence SNPs detected between nucleotide positions 20399 and 20604. Interestingly, the 
ratio of purines and pyrimidines was calculated as eight to seven showing an equal share 
relating to two groups of nitrogenous bases within SNP cluster. Furthermore, this large 
number of SNPs was identified only in ep90. The further analyses of Sanger sequenced 
data could not confirmed differences in SNP accumulation between the egg isolates due to 
missing data for late passages of A isolate and early passages of A1 isolate. However, 
these Sanger sequenced datasets suggest that a degree of SNP accumulation can random 
and its presence in egg passages strongly depends on analysed egg isolate. The 
investigation of independent SNPs and SNP clusters in viral genome detected a similarity 
of SNP appearance regarding to a small number of independent SNPs in the A and A1 
isolate and their accumulation in further egg passages.  
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  Interestingly, a similar observation was made in the C isolate where the appearance of 
SNP clusters and independent SNPs were analysed in table 3.7. The ep20 of the C isolate 
was found as a mixture of one independent SNP and SNP cluster separated from each other 
by 577 bp. The highly polymorphic encoding region (11 SNPs) formed by consensus 
sequence SNPs was identified between nucleotide positions 21084-21137 (53 bp). In 
addition, a very unique situation was spotted within the SNP cluster between nucleotide 
positions 21210-21265 with an insertion of three nucleotides (G, T and A) in the C isolate. 
The nature of the highly polymorphic encoding regions in ep20 was also confirmed in ep40 
as SNP cluster (four SNPs) shown between nucleotide positions 21272-21350 with 533 bp 
gap to the next independent SNP. The investigation of ep60 has shown no SNP cluster 
formation across the S1 subunit encoding region but identified independent SNPs. 
Interestingly, ep90 was confirmed as the egg passage that  included a small polymorphic 
encoding region formed of three neighbourhood residues identified between genomic 
positions 21165-21167 with a residue switch (A and T nucleotide) at nucleotide positions 
21165 and 21166. The highly polymorphic encoding regions were also confirmed as two 
clusters of eleven and five consensus sequence SNPs between nucleotide positions 20451-
20491 and 20595-20627 in ep80. In addition, similar to the SNP cluster of ep90 (A1 
isolate), the purines and pyrimidines in two SNP clusters of ep90 was balanced at the ratio 
of five to six and two to three. Furthermore, the observation confirmed ep80 as the only 
egg passage without independent SNPs in C isolate and the biggest SNP accumulation in a 
form of cluster identified in the S1 subunit encoding region. Further investigation showed 
that SNPs and their features strongly depend on the analysed IBV isolates and their egg 
passages. However, the unique SNPs found in egg passages of C isolate mirror the 
situation of SNP clusters and independent SNPs analysed in the early egg passages of A 
isolate and in the later egg passages of A1 isolate. Further investigation confirmed lack of 
correlation between single SNPs in four analysed isolates but showed a pattern of SNP 
cluster appearance in the investigated egg passages of A, A1 and C isolate.  
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Table 3.7. Results of Sanger sequencing reads relating to the additional SNPs and SNP 
clusters found in S1 subunit of C isolate after indicating to the sequence of ep4. White = 
not sequenced, yellow = failure of Sanger sequencing reads, orange = minor SNP, red = 
lack of SNP, green = SNP at consensus sequence level and NIL = gap. 
C isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
20448 T      A     
20451 C        G   
20452 G        C   
20460 C        T   
20461 T        G   
20464 C        T   
20465 A        G   
20468 G        A   
20481 A        T   
20483 C        A   
20485 A        C   
20489 G      R     
20491 T        C   
20595 C        T   
20600 T        C   
20602 T        G   
20625 A        G   
20627 G        C   
21084 T  C         
21103 C  G         
21116 G  T         
21124 G  A         
21129 G  C         
21130 C  A         
21131 A  T         
21137 T  A         
21165 T         A  
21166 A         T  
21167 C         A  
21210 NIL  G         
21224 NIL  T         
21265 NIL  A         
21272 G    A       
21280 T    A       
21288 T    A       
21350 G    A       
21490 T         W  
21838 A    T     T  
21839 A         T  
21842 A  T         
21853 G      T     
21865 T      A     
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Table 3.8. The S1 subunit of D isolate with additional SNPs not identified previously with 
454 pyrosequencing reads indicated to the sequence of ep4. White = not sequenced, yellow 
= failure of Sanger sequencing reads, orange = minor SNP, red = lack of SNP, green = 
SNP at consensus sequence level and NIL = gap. 
D isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
20357 T      A     
20358 A      T     
20488 G     R      
20964 C         A  
20965 T         C  
21254 A      C     
21270 G     A      
21329 A      T     
21342 A      G     
21343 T      A     
21350 A     C      
21373 G     A      
21606 C    T       
21607 NIL    T       
21617 C    A       
21619 G    C       
21627 A    C       
21633 A    C       
21634 G    A       
21635 T    A       
21637 A    T       
21822 T      G     
21825 A      C     
21831 T      G     
21832 A     M      
21853 A    T       
21859 A           T     
21867 C      G     
21895 A     M      
21980 G    A       
21986 G      A     
 
 
 The constantly changing composition of the viral genome was also investigated as the 
SNP dynamics in the D isolate. The analysed Sanger sequenced datasets showed a mixture 
of SNP clusters with various lengths and independent SNPs across the S1 subunit encoding 
region (table 3.8). Interestingly, the largest SNP cluster was shown in ep40 with ten SNPs 
at consensus sequence level in the viral genome between nucleotide positions 21606-
21637. Furthermore, the analyses of SNP composition in this highly polymorphic encoding 
region showed 40 % of C residues and 30 % of each A and T residues across the 
investigated ep40. In addition, this particular SNP cluster is the only cluster where G 
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residue is not observed making it unique among SNP active encoding regions in four egg 
isolates. The SNP cluster formation usually involved a minor SNPs or/and SNPs at 
consensus sequence level but insertions of additional SNPs in investigated Sanger 
sequenced egg passages were rare. However, nucleotide position 21607 was identified with 
insertion of a T residue in the SNP cluster visible in ep40 (D isolate) causing a frameshift 
mutation. The insertion in viral genome could possibly be responsible for the attenuation 
process by changing the reading frame resulting in a completely different translation from 
the original. The Sanger sequence reads identified independent SNPs in ep50-60 without 
further continuation of genomic change in later egg passages. Interestingly, further 
investigation also analysed the appearance of SNPs in ep60 resulting in identification of 
two SNP clusters combined with three and six consensus sequence SNPs between 
nucleotide positions 21329-21343 and 21822-21986. Furthermore, ep70 and ep90 were an 
exception among Sanger sequenced egg passages of the D isolate showing the low amount 
of polymorphism previously undetected with 454 pyrosequencing in ep110. The further 
analyses has shown unique situation relating to SNP appearance in S1 subunit encoding 
region without further accumulation (SNP clusters and independent SNPs) between ep40-
60 not identified in investigated A, A1 and C isolate. However, similar to previously 
analysed egg isolates, the D isolate has shown a number of independent SNPs with random 
appearance across the S1 subunit but also SNP clusters without further accumulation in 
further egg passages.  
 
3.5.4   The summary of SNP accumulation in S1 subunit  
 
 The total number of SNPs identified within four isolates of S1 subunit across all 
investigated egg passages at >5 % frequency was included in figure 3.5. The Sanger 
sequenced data clearly shows differences in SNP accumulation but also in the  number of 
genomic changes in egg passages of A, A1, C and D isolate which might be involved in the 
process of attenuation. According to the bar chart below C isolate was shown as one of the 
most polymorphic across all investigated isolates. Interestingly, Sanger sequenced data 
identified rapid SNP accumulation in a form of visible peak in ep20 (12 SNPs) followed by 
the reduction of SNPs in ep40 (five SNPs) - ep60 (four SNPs) and rapid SNPs 
accumulation in a case of ep80 (16 SNPs) in C isolate. Interestingly, C isolate was found as 
only one across four egg isolates with visible polymorphism in ep20 and ep80 and 
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decreased number of SNPs in ep30-70. The D isolate was identified with polymorphism 
between ep40-60 where analyses of Sanger sequence data observed SNP accumulation in 
ep40 (12 SNPs) and ep60 (13 SNPs). 
 
Figure 3.5. The total number of SNPs across all investigated egg isolates with the final 
reads of ep110 (>5 % freq.). The diagram presents number of genomic mutations in each 
of analysed egg passage. The bar chart illustrates polymorphism across four egg isolates 
presented by different colours. The table below bar chart presents exact number of SNPs 
identified in egg passage and egg isolate of interest. The zero numbers marked as red 
colour relates to failure of Sanger sequencing reads.  
 
 Interestingly, D isolate was characterised by rapid decreasing of SNPs in ep70 with a 
continuous trend of small numbers of polymorphisms in later egg passages such as ep90 
(three SNPs). Similar to D isolate, A1 isolate was found with SNP accumulation only in 
ep50 (10SNPs), ep70 (seven SNPs) and ep90 (15SNPs). Interestingly, further observation 
identified the phenomenon of rapid SNPs accumulation in ep90 (A1 isolate) and ep80 (C 
isolated) as the highest number of genomic changes ever observed in S1 subunit of single 
egg passage.  The lowest SNP accumulation across all investigated egg passages was seen 
in the A isolate. However, Sanger sequenced data clearly showed the A isolate with rapid 
SNP accumulation in ep10 (nine SNPs). Furthermore, intensive polymorphism in ep10 was 
not continued in further egg passages showing decreasing tendency of genomic changes in 
ep30 and ep50 (five SNPs) and lack of ability to investigate polymorphisms in later egg 
passages due to failure of Sanger sequencing reads. Interestingly, Sanger sequenced data of 
S1 subunit clearly shows a tendency of at least two visible bars due to significant SNP 
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accumulation in four egg isolates. In addition, each egg isolate has been identified with 
rapid accumulation but also quick reduction of SNPs across all investigated egg passages 
such as A1 and C isolates presented intensive polymorphism in ep90 comparing to SNP 
reduction in A and D isolates. Pyrosequencing data of S1 subunit clearly identified all four 
egg isolates with similar numbers of mutations in ep110 suggesting that additional SNP 
appearance in previous egg passages do not have an influence on number of SNPs in ep110 
of S1 subunit. 
 
3.5.5    The SNPs investigation in S2 subunit (part 1) 
 
 The 454 pyrosequencing data showed that the first 982 bp of the S2 subunit encoding 
region presents high polymorphism in all four isolates. Therefore, further investigations 
included Sanger sequenced egg passages to analyse the occurrence of SNPs within the 
viral populations. The studies of known wild IBV strains show the S2 subunit, as more 
conserved and larger part of spike encoding region (built up with 1855 bp) compared to the 
S1 subunit found as highly polymorphic within its size of 1607 bp. However, the analyses 
of pyrosequencing data identified the D isolate with seven SNPs with various frequencies 
in the viral population of the S2 subunit compared to three SNPs across the S1 subunit 
encoding region. A similar observation was made in the A1 isolate detected with three 
SNPs relating to the S2 subunit and only one SNP identified in the S1 subunit. This 
observation suggests unusual occurrences in viral genome where, in lack of immune 
pressure, the conserved region of S2 subunit was identified with more mutations than S1 
subunit which is highly polymorphic under immune pressure.  
 
 The results of the 454 pyrosequencing data also confirmed the presence of common SNPs 
shared between investigated egg isolates (table 3.9). This situation is clearly visible at 
nucleotide position 22224 where a synonymous SNP was identified in the C and D isolate 
with >50 % SNP frequency in ep110. Interestingly, only D isolate (no data of ep10-100 for 
C isolate) showed minor SNPs which in ep70-80 returned to the original nucleotide found 
in ep4 but was confirmed as SNPs at consensus sequence level in ep110 with a SNP 
frequency of 56 %. A common residue change was also observed at nucleotide position 
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22421 in the A and A1 isolate where the pyrosequencing data identified both egg isolates 
with a SNP at consensus sequence level with vary SNP frequency in ep110. 
 
Table 3.9. The SNPs found in more than one egg isolate (S2 subunit) with specification of 
mutation NS/S (Non-synonymous/Synonymous) after indicating to the sequence of ep4. 
White = not sequenced, yellow = failure of sequencing reads, orange = minor SNP, red = 
lack of SNP and green = SNP at consensus sequence level. 
The nucleotide position 22224 
NS/S 
 
                Ep # 
Egg isolate 
4 Freq 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq 
% 
S C G 80           T 52 
S D G 88  K  K  K G G   T 56 
The nucleotide position 22240 
NS/S     Ep # 
Egg isolate 
4 Freq 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq 
% 
S C G 100           T 58 
S D G 100        T T T T 52 
The nucleotide position 22421 
NS/S     Ep # 
Egg isolate 
4 Freq 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq 
% 
S A C 100   M  M M M A A  A 52 
S A1 C 100     A A A    A 98 
 
Interestingly, the number of SNP appearing in more than one egg isolate of S2 subunit 
(three SNPs) was similar to the S1 subunit encoding region (two SNPs). However, the SNP 
frequency was less diverse in S2subunit (52-98 %) comparing to S1 subunit (1.1-100 %) 
which might indicate a substantial impact on SNP accumulation in Sanger sequenced egg 
passage. Furthermore, the high SNP frequency observed in deep sequenced data of ep110 
seems to have an influence on the degree of SNP accumulation presenting minor SNP 
which gradually become a SNP at consensus sequence level or accumulate directly at 
consensus sequence level in earlier egg passages.  
 
 Further analyses also confirmed a number of SNPs that occurred only in one of the 
investigated isolates (shown in a table 3.10). The relatively high SNP frequency (54 %) 
was obtained from nucleotide position 22459 in ep110 of the D isolate showing a non-
synonymous SNP (leucine with isoleucine) in ep70 and a minor SNP (represented with 
ambiguity code) in ep80-100 across viral population.  The A isolate was identified with 
two independent SNPs at nucleotide positions 22285 and 22504 across the analysed S2 
subunit encoding region with a ≤50 % SNP frequency in ep110. Further investigation into 
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SNPs using 454 pyrosequencing also showed four synonymous SNPs with a very low 
frequency (≤2.2 %) detected only in ep110 of the D isolate. Interestingly, the SNP with 
frequency ~50 % in ep110 are visible as a mixture of minor SNPs and SNPs at consensus 
sequence level within regular Sanger sequenced egg passages. However, the SNPs 
accumulation not always seems to be logical showing sometimes the SNP at consensus 
sequence level with a change to minor SNP in later egg passages (D isolate – nucleotide 
position 22459).   
 
Table 3.10. The outcomes of unique SNP investigation in A, C and D isolate from Sanger 
sequenced egg passages and final results of 454 pyrosequencing in S2 subunit (part 1). The 
specification of mutation NS/S (Non-synonymous/Synonymous) was indicated to the 
sequence of ep4. White = not sequenced, yellow = failure of sequencing reads, orange = 
minor SNP, red = lack of SNP and green = SNP at consensus sequence level. 
A isolate 
 NS/S 
 
                Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq 
% 
NS 22285 G 100       K    T 50 
NS 22504 G 100           A 5 
C isolate 
NS/S     Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq 
% 
NS 22201 T 100           A 4.6 
D isolate 
NS/S     Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq 
% 
NS 22459 C 100       A M M M A 54 
S 22476 T 100           A 2.2 
S 22633 C 100           T 1.5 
S 22696 C 100           T 1.7 
S 22717 T 100           C 1 
 
 
3.5.6    Other polymorphism within S2 subunit (part 1)  
 
 Further analyses of the S2 subunit (part1) encoding region showed SNPs previously not 
detected using 454 pyrosequencing data in ep110. In addition, a substantial number of 
SNPs investigated in the S2 subunit were common for more than one egg isolate (table 
3.11).  
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Table 3.11. The shared SNPs identified in S2 subunit (part1). The information included 
reference nucleotide position in ep4, a SNP change in each of egg isolates and the details 
of detected SNPs. White = not sequenced, yellow = failure of Sanger sequencing reads, 
orange = minor SNP, red = lack of SNP and green = SNP at consensus sequence level. 
The nucleotide position 21994 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A A   R    R    
A1 A   R        
D A  R       R  
The nucleotide position 22002 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A T       K    
D T        K   
The nucleotide position 22006 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A A       R    
A1 A   R        
D A      R     
The nucleotide position 22048 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A G       R    
A1 G     R      
C G  A         
D G        R   
The nucleotide position 22051 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A G       R    
A1 G     R      
The nucleotide position 22117 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A G      R R R R  
A1 G     R      
D G  R    R     
The nucleotide position 22162 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A G   R R R R R R   
D G    R R R R R   
The nucleotide position 22561 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A C   Y Y Y Y Y Y Y  
A1 C  Y  Y Y      
D C      Y Y Y Y Y 
The nucleotide position 22768 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A1 T  C C      C  
C T  C         
D T  C  C  C  C   
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Interestingly, the A isolate was found to have the highest number of SNPs commonly 
identified between the four egg isolates. Further investigation showed that out of 27 SNPs 
identified in the A isolate, eight SNPs were also confirmed within the A1, C or D isolate. 
An interesting example is the SNP at nucleotide position 22048 within the SNP clusters of 
A isolate (ep70) and C isolate (ep20) also identified as independent SNP in A1, and D 
isolate. The generated Sanger sequence data confirmed a similarity between the A, A1 and 
D isolate relating to common SNPs in the viral population such as SNP detected at 
nucleotide position 22006, clearly visible in a SNP cluster of the A isolate (ep70), but also 
as an independent minor SNP  in the D isolate (ep60) and  the A1 isolate (ep30). The 
common SNPs were also observed at nucleotide position 22117 as a minor SNP found in 
the A isolate (ep60-90), the A1 isolate (ep50) and D isolate (ep20, ep60). The analyses of 
Sanger sequence data identified the phenomenon of common SNPs when comparing the A 
and D isolate at nucleotide position 22002 where a minor SNP (represented with ambiguity 
code) was observed in ep70 of the A isolate and ep80 of the D isolate. Interestingly, the 
majority of SNPs identified across A, A1, C and D isolate have been shown as independent 
SNPs with appearance in different Sanger sequenced egg passages for each egg isolate. 
Furthermore, there is also a small correlation between SNPs observed at this same 
nucleotide position showing SNP continuation within a few egg passages in more than one 
egg isolate.  
 
 The further investigation of egg isolates identified a number of SNPs that were unique to 
each viral population, identified as a SNP cluster or as independent SNPs in the S2 subunit 
(part1) encoding region. The analyses of sequence data in the A isolate showed no 
additional SNPs in ep20 but confirmed independent SNPs in ep30 and ep50 without further 
continuation in later egg passages (table 3.12). Interestingly ep40 and ep60 were identified 
with no additional SNP or/and SNP clusters. However, the later egg passages such as in 
ep80 was shown with SNP cluster (six SNPs at consensus sequence level) identified 
between nucleotide positions 22350 and 22370 without continuation in further egg 
passages. Interestingly the A isolate has shown SNP accumulation in early egg passages of 
S1 subunit comparing to polymorphism found in later egg passages of S2 subunit 
supported by the appearance of SNP cluster and a number of independent SNPs.   
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Table 3.12. The unique SNPs analysed in S2 subunit (part 1) of A, A1and D isolate. White 
= not sequenced, yellow = failure of Sanger sequencing reads, orange = minor SNP, red = 
lack of SNP and green = SNP at consensus sequence level. 
A isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
21994 G       R    
22002 T       K    
22006 A       R    
22048 G       R    
22051 G       R    
22117 G       R    
22162 G       R    
22285 G        T   
22312 G   R        
22350 G        T   
22354 G        A   
22358 T        A   
22365 A        T   
22370 C        T   
22426 G     A   A   
22430 G     A      
22455 C     Y      
22486 G   K        
22540 C   Y        
22593 C         Y  
22643 C         Y  
22738 T     C      
22766 C       T    
 A1 isolate  
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
22242 T    A       
22243 T    A       
22272 C    A       
22295 G    T       
22343 C      G     
22441 C   T        
22442 G   A        
22443 T   A        
22448 T    A       
22462 C   T        
22616 C    T  T     
22769 C         G  
D isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
22002 T        K   
22048 G        R   
22162 G    R R R R R   
22388 C         A  
22436 G       T    
22459 C      S  S   
22545 C        Y   
22561 C      Y Y Y Y Y 
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 According to the analysed Sanger sequenced data the unique SNPs were identified in early 
egg passages of the A1 isolate showing ep30 with four consensus sequence SNPs 
identified between nucleotide positions 22441-22462 (table 3.12). Interestingly, the SNP 
accumulation in this encoding region was equally dominated by T and A residue 
appearance in the SNP cluster. In addition, a similar conclusion was made in ep40 with 
four consensus sequence SNPs between nucleotide positions 22242-22295 where A and T 
residues accounted for 100 % of SNPs. Furthermore, SNP cluster in ep40 was separated by 
150 bp gap from two consensus sequence SNPs found at nucleotide positions 22448 and 
22616. Interestingly, further investigation showed lack of unique SNP in ep50 of the A1 
isolate and decreasing polymorphism in ep60 (two SNPs) and in ep90 (one SNP) across S2 
subunit encoding region. The analysed sequence data clearly showed the differences in 
additional SNP accumulation and continuation between the A isolate (ep70-80) and A1 
isolate (ep30-40) in S2 subunit. The difference was also spotted between S1 and S2 subunit 
of A1 isolate presenting different level of SNP appearance within Sanger sequenced egg 
passages relating to the SNP clusters and independent SNPs.  
 
 The high polymorphism was detected in the C isolate (ep20) shown as SNP cluster (seven 
consensus sequence SNPs) between nucleotide positions 21999 and 22105 separated by a 
540 bp gap from the next independent SNP in S2 subunit (part1) – data not shown. Further 
investigation clearly showed an equal domination of A and G residues confirmed to be 84 
% within the SNP cluster. However, further investigation of polymorphism in the C isolate 
could not be continued due to the failure of the Sanger sequencing reads in all egg 
passages. The analysed sequence data identified in ep20 and ep40 of D isolate a lack of 
polymorphisms with an exception of nucleotide position 22162 (ep40-80) detected as a 
minor SNP (represented with ambiguity code-R). The further investigation of Sanger 
sequencing reads clearly indicated genome changes in later egg passages of the D isolate 
by increasing numbers of SNPs in ep60, with three minor SNPs randomly spread across the 
investigated S2 subunit (part1) encoding region. Interestingly, the SNP detected at 
nucleotide position 22561 was also confirmed with accumulation in ep70-100. The further 
investigation identified ep80 as highly active egg passage presenting unique minor SNPs 
without further continuation. Furthermore, the investigation of SNPs previously not 
detected using 454 pyrosequencing data showed decreasing polymorphism in ep90. The 
SNP accumulation of D isolate in the later egg passages was similar to the observation 
made in the A isolate presented with polymorphism in ep70-80 across S2 subunit encoding 
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region. In addition, the pattern of SNP accumulation was also spotted between S1 and S2 
subunit of D isolate shown as highly active only in later egg passages. Furthermore, the 
investigation of the D isolate identified unique SNP continuation (minor SNPs) at two 
nucleotide position (22162 and 22561) in Sanger sequenced egg passages never seen 
before in previous egg isolates including ep110.  
 
3.5.7   The overview of polymorphism across S2 subunit (part 1)  
 
 
 Figure 3.6. The total number of SNPs across all investigated egg isolates in S2 subunit 
(part 1) with the final reads of ep110 (>5 % freq.). The diagram presents number of 
genomic mutations in each of analysed egg passage. The bar chart illustrates 
polymorphism in a form of bars across four egg isolates presented by different colours.  
The table below bar chart presents exact number of SNP identified in egg passage (ep10-
110) and egg isolate of interest. The zero numbers marked as red colour relate to failure of 
Sanger sequencing reads. 
 
The Sanger sequence data has shown crucial differences in accumulation of SNPs across 
egg passages in S1 and S2 subunits. Interestingly, A1 egg isolates has shown visible and 
rapid accumulation of mutation in ep20-30 comparing to A and D isolate identified with 
accumulation but also reduction of SNPs within ep20-60 (figure 3.6). 
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 Interestingly, Sanger sequenced data has shown a phenomenon of increasing 
polymorphism (A isolate) and decreasing number of mutations (D isolate) or vice versa 
within ep20-60. A1 isolate has been found with growing SNP numbers in ep20-30. 
Interestingly, the number of SNPs in ep30-40 of A1 isolate did not change (seven SNPs) 
but started to decrease continuously presenting one SNP in ep90. The further investigation 
of genomic changes in A, A1 and D isolate have shown ep60 as a crucial point where 
polymorphism change rapidly and strongly depends on egg isolate. The most visible SNP 
accumulation was identified in ep70 of A isolate (18 SNPs) but also ep80 of D isolate (14 
SNPs). However, these two visible bars were continued as rapid reduction of 
polymorphism followed by detection of only three SNPs in ep100 (D isolate) and lack of 
any SNPs in ep100 (A isolate). Interestingly, further analyses of pyrosequencing data have 
shown similar level of SNP accumulation in ep110 varies from one SNP (A1 isolate) to 
three SNPs (D isolate).  
 
 The comparison of two spike subunits could not be fully possible due to failure of Sanger 
sequencing assay in  S1 subunit (few egg passages of A, A1, C and D isolates) and S2 
subunit (C isolate). However, the figure 3.5 and figure 3.6 clearly showed the differences 
of SNP accumulation in egg passages between two subunits of spike encoding region.  S1 
subunit was found with visible bars presented during investigation of egg isolates without 
an impact relating to further accumulation/reduction of SNPs shown as crucial point in 
ep60 of S2 subunit.  In addition, constant changes in number of SNPs across spike 
encoding regions were more visible in S1 subunit. However, the total number of genomic 
mutations was greater in S2 subunit presenting increased polymorphisms in ep70 (A 
isolate) and ep80 (D isolate). Interestingly, both subunits of spike encoding region were 
identified with decreasing polymorphisms in ep100 across four egg isolates. In addition, 
the situation of ep110 presenting higher number of SNPs in S2 subunit comparing to S1 
subunit pyrosequencing data does not explain the sudden reduction of SNP numbers in 
later egg passages of spike encoding region. According to the results the highest 
polymorphism was observed in A and D isolate (three SNPs) and the lowest in A1 isolate 
(one SNP) of ep110. 
 
 
 
73 
 
 
3.5.8    The common SNPs found only in the nucleocapsid  
 
 Further investigation indicated SNPs in nucleocapsid encoding region of pyrosequencing 
data (ep4) at <43 % SNP frequency and Sanger sequenced egg passages (table 3.13). 
Interestingly, the SNPs with a low frequency were identified in ep110 of four egg isolates 
at the nucleotide position 26792 and 26793 also visible in most of  investigated Sanger 
sequenced egg passages (A, C, D isolate) and ep70-90 of A1 isolate (nucleotide position 
26792). Furthermore, the SNP frequency of ep110 varied across investigated egg isolates 
from ~20 % in A and A1 isolate to ~40 % in C and D isolate. In addition, a similar 
situation was detected at nucleotide position 26793 identified in the C and D isolate as 
having 31-36 % SNP frequency in ep110 whereas A and A1 isolate showed a decreased 
SNP frequency (17-26 %). Interestingly, the low frequency (>43 %) identified in ep110 
(nucleotide position 26792-26793) might be a sign of error in the 454 pyrosequencing data 
due to presence of poly A tract in the viral genome.  The further analysis across the 
nucleocapsid indicated the presence of SNPs which are visible in ep4 at low SNP 
frequency (<30 %) such as the nucleotide position 26795 with 15 % SNP frequency in ep4 
of A1, C and D isolate. There was a lack of SNPs in Sanger sequenced egg passages except 
for deep sequenced ep110 identified with the increasing SNP frequency in D isolate (36 %) 
and C isolate (23 %) but stable in A1 isolate (15 %) compared to 15 % SNP frequency rate 
in ep4. Interestingly, the nucleocapsid encoding region has shown a SNP accumulation 
with SNP frequency (<43 %) never seen before in the spike encoding region. The 
polymorphism could be identified in all previous egg passages with a SNP frequency as 
low as ~30 % in all investigated egg isolates. These data presented unusual accumulation 
of SNPs with low SNP frequency at genomic positions in more than one egg isolate. 
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Table 3.13. The common SNPs appearance within the egg isolates in the nucleocapsid 
encoding region with SNP frequency ≤ 33 % in ep4. The specification of mutation NS/S 
(Non-synonymous/Synonymous) was included. White = not sequenced, yellow = failure of 
sequencing reads, orange = minor SNP, red = lack of SNP and green = SNP at consensus 
sequence level. 
The nucleotide position 26791 
 NS/S 
 
                Ep # 
Egg isolate 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
S A C 2.9           C 8.7 
S A1 C 2.6           C 13.1 
S D C 2.6           C 8.6 
The nucleotide position 26792 
NS/S     Ep # 
Egg isolate 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
S A G 31 G G G  G G G G G G G 29 
S A1 G 31       G G G  G 20 
S C G 31 G G G G   G G G G G 40 
S D G 31  G G G G G G R G G G 43 
The nucleotide position 26793 
NS/S     Ep # 
Egg isolate 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
S A A 33 A A A  A A A A A A A 26 
S A1 A 33       A A A  A 17 
S C A 33 A A A A   A A A A A 36 
S D A 33  A A A A A A A A A A 31 
The nucleotide position 26795 
NS/S     Ep # 
Egg isolate 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
S A1 C 15           C 15 
S C C 15           C 23 
S D C 15           C 36 
 
 
  The next interesting observation was made at nucleotide position 27124 where SNPs in 
viral genome were observed during the egg passages in D isolate (table 3.14). This 
phenomenon was observed only once across the nucleocapsid encoding region with a 
substantial difference in frequency between ep4 (1.2 %) and ep110 (100 %) also detectable 
as consensus sequence SNPs in ep70-100. However, during the investigation of the SNPs 
within the viral populations, the high SNP frequency in ep110 mirror the situation of SNPs 
appearance between egg passages of the A and D isolate. A good example is the  non-
synonymous SNP analysed in the A isolate at nucleotide position 26845 where, with 99 % 
frequency in ep110, the minor SNP was identified in ep50 with further SNP continuation 
(ep60-90) at consensus sequence level across the viral population. Further investigation 
into the D isolate led to a very similar observation, confirmed as a non-synonymous minor 
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SNP at nucleotide position 26006 detected in ep40-70 with change at consensus sequence 
level in ep80 and 99 % SNP frequency in ep110.  
 
Table 3.14. The SNPs in the nucleocapsid encoding region of A, C and D isolate relating 
to SNP frequency (25-100 %) in ep110. NS/S = Non-synonymous/Synonymous. White = 
not sequenced, yellow = failure of sequencing reads, orange = minor SNP, red = lack of 
SNP and green = SNP at consensus sequence level. 
A isolate 
 NS/S 
 
                Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
NS 26312 G 100           A 60.3 
S 26394 C 100       Y Y T  T 98 
NS 26557 T 100      C C C C  C 99 
NS 26729 C 100 Y  Y  Y T T Y   T 40.8 
NS 26845 C 100     Y T T T T  T 99 
C isolate 
NS/S     Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
NS 26213 G 100  A        R A 25 
NS 26224 G 100          K T 62 
NS 26563 A 100          G G 44 
D isolate 
NS/S     Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
NS 26006 G 100    R R R R A A A A 99 
NS 27022 A 100        M C C C 86.8 
NS 27124 A 1.2       A A A A A 100 
 
 
 The investigation of pyrosequenced data has shown that SNPs appearing within the 
quasispecies of Sanger sequenced egg isolates can be identified with decreased SNP 
frequency in ep110. The deep sequence data presented genomic positions in nucleocapsid 
encoding region where the SNP frequency varies (25-100 %) as seen in table 3.14.  The A 
isolate perfectly illustrates the dynamics of the viral genome regarding to non-synonymous 
SNPs at nucleotide position 26729 detected in early egg passages as the minor SNP with a 
change at consensus sequence level in ep60-70 bur relatively low SNP frequency in ep110 
(40.8 %). The interesting fact is that the non-synonymous SNP at nucleotide position 
26312 was undetected in Sanger sequenced egg passages but was identified with a 
relatively high frequency (60.3 %) in ep110. The C isolate was found with mutation at 
nucleotide position 26224 where a non-synonymous SNP was detected in ep100 (IUPAC 
Ambiguity Code-K) resulting in change at consensus sequence level presented by 62 % 
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frequency rate in ep110. However, the further SNPs identification in previous egg passages 
is an open question due to the failure of the Sanger sequencing reads. The analysed Sanger 
sequenced data also identified interesting SNPs at nucleotide position 27022 in the D 
isolate observed in ep80 as minor SNP, ep90-100 with a change at consensus sequence 
level and the final confirmation in ep110 (freq.86 %).  
 
 The 454 pyrosequencing data of A and A1 isolates also showed a number of SNPs with 
low frequency (<20 %) where in most cases the SNPs were undetectable during the Sanger 
sequenced egg passages within all four egg isolates. The A isolate presents four different 
nucleotide positions as a mixture of synonymous and non-synonymous SNPs with a low 
SNP frequency (≤ 5.8 %) detected only in ep110 (table 3.15).The further investigation also 
confirmed two low (≤1.5 %) SNP frequency identified within the viral population of ep110 
in A1 isolate.  Further investigation of Sanger sequenced data identified a number of 
genome positions in the A isolate such as nucleotide position 26002 where a minor non-
synonymous SNP (represented with ambiguity code) was confirmed in all investigated 
passages with a 6.9 % SNP frequency in ep110.  The D isolate presents the only one SNP 
at nucleotide position 26064 identified as minor SNP in ep80 with low SNP frequency 
(<5.2 %) in ep110. The 454 pyrosequencing data has shown different level of SNP 
accumulation in ep110 of four egg isolates. The further investigation using regular Sanger 
Sequencing method has shown that high SNP frequency (>85 %) presents a regular and 
logical SNP accumulation in previous egg passages mostly in a form of minor SNPs which 
at some point become the SNP at consensus sequence level across nucleocapsid encoding 
region. Furthermore, the decreasing SNP frequency in ep110 has shown a dynamic but 
very often random SNP accumulation in Sanger sequenced egg passages. Interestingly, the 
SNP frequency (<60 %) in ep110 does not ensure appearance of SNPs in the viral 
population of previous egg passages. In addition, nucleotide positions with SNP frequency 
(>15 %) were mostly identified as too low for SNP detection using the Sanger sequencing 
method. However, the exceptions are present suggesting that a viral population might 
develop a minor SNP in the genome which stays at constant level during the Sanger 
sequenced egg passages without further increasing of accumulation.    
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 Table 3.15. The reduced polymorphism in the nucleocapsid encoding region of four egg 
isolates after Sanger sequencing and Pyrosequencing. NS/S = Non-
synonymous/Synonymous was included. White = not sequenced, yellow = failure of 
sequencing reads, orange = minor SNP, red = lack of SNP and green = SNP at consensus 
sequence level. 
A isolate 
 NS/S 
 
                Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
NS 26002 G 100 R R R R R R R R R R A 6.9 
NS 26140 C 100       Y    T 14.9 
S 26331 G 100           A 1.3 
NS 26398 C 100           A 2.2 
NS 26845 C 100           T 5.8 
NS 26919 A 100           C 1.9 
A1 isolate 
NS/S     Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
NS 26291 C 100           T 1.4 
NS 26347 C 100           A 1.5 
C isolate 
 NS/S 
 
                Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
S 26328 C 100           T 1.5 
S 26361 C 100           T 1 
D isolate 
NS/S     Ep # 
Nucl. # 
4 Freq. 
% 
10 20 30 40 50 60 70 80 90 100 110 Freq. 
% 
S 26064 T 100        Y   C 5.2 
 
 
3.5.9    The additional SNPs of nucleocapsid encoding region 
 
 The further investigation of previous egg passages using Sanger sequencing highlighted a 
substantial number of SNPs across the nucleocapsid encoding region previously not 
detected in the 454 pyrosequencing data. The uncovered SNPs were identified in the C 
isolate (133) but also A isolate (38), D isolate (36) and within A1 egg passages (15). In 
most cases the SNPs detected across the investigated isolates were an independent SNPs 
identified only once within one isolate. However, a small fraction of SNPs showed as 
continued SNPs in the viral genome clearly visible in a Sanger sequenced egg passages of 
more than one egg isolates (table 3.16). The interesting sequence data was analysed at 
nucleotide position 25924 identified as SNP visible in the A isolate (ep20-100), D isolate 
(ep20-30, ep50-100), A1 isolate (ep50), and C isolate (ep100). In addition, a very similar 
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situation of SNPs identified in all four egg isolates was spotted at genome position 26101 
and 26772 identified as a highly polymorphic with a different degree of SNP accumulation 
within four egg isolates.  Further investigation of regular Sanger sequencing data also 
identified the polymorphism only in egg passages of the A, C and D isolate across the 
nucleocapsid such as the nucleotide position 26948 with the minor SNP (presented as 
ambiguity code) identified in the D isolate (ep20-70, ep90-100), A isolate (ep70-90), and C 
isolate (ep40). The polymorphism was also identified at nucleotide position 27128 with 
various degrees of SNP accumulation within the A, A1 and D isolate due to replacement of 
the C residue with a T residue forming a consensus sequence SNPs (A isolate) or mixture 
of minor SNPs (A1 and D isolate) within the viral population. In some cases the mutation 
in viral genome was detectable only in two egg isolates such as the A and C isolate with 
SNPs at nucleotide positions 26067 and 26068. Interestingly, SNP identification at 
nucleotide position 26068 confirmed unusual appearances of two nucleotides relating to a 
change of a C residue in ep30 of the A isolate (G residue) and the replacement in ep60 of 
the A1 isolate (T residue). The overlapping SNPs were also found as common for A and D 
isolate showing minor SNPs accumulation in Sanger sequenced egg passages identified at 
the nucleotide position 26887. These sequence data shows that some SNPs could not be 
detected using 454 pyrosequencing reads because of their disappearance before the final 
investigation of ep110. In addition, analysed Sanger sequenced data clearly presents the 
dynamics at common nucleotide positions with consensus sequence SNPs visible in early 
egg passages and a logical continuation of these SNPs in more than one investigated egg 
isolate. However, there are a few nucleotide positions in a nucleocapsid encoding region 
with a polymorphism showing a continuation of SNPs without the change at consensus 
sequence level. Furthermore, the analyses of Sanger sequence data have shown a number 
of independent SNPs identified at this same genomic position but in different egg passages 
of A, A1, C and D isolate.  
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Table 3.16. The common SNPs identified in the nucleocapsid encoding region compared 
to ep4 reference sequence. The table presents the minor SNPs or consensus sequence SNPs 
in four egg isolates on specific nucleotide position. White = not sequenced, yellow = 
failure of Sanger sequencing reads, orange = minor SNP, red = lack of SNP and green = 
SNP at consensus sequence level. 
The nucleotide position 25924 
                             Ep # 
Egg isolate                             
4 10 20 30 40 50 60 70 80 90 100 
A A  C C C C C C C C C 
A1 A     C      
C A          C 
D A  C C  C C C C C C 
The nucleotide position 26067 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A G          K 
C G      T     
The nucleotide position 26068 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A C   G        
C C      T     
The nucleotide position 26101 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A G     R      
A1 G     R A  R   
C G      A     
D G   R R R R R    
The nucleotide position 26772 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A C   Y  Y  Y    
A1 C Y Y Y Y Y Y  Y Y Y 
C C       A    
D C  Y Y   Y Y    
The nucleotide position 26887 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A C   Y Y Y Y Y Y Y  
D C   Y Y Y      
The nucleotide position 26948 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A C       Y Y Y  
C C    Y       
D C  Y Y Y Y Y Y  Y Y 
The nucleotide position 27128 
                            Ep # 
Egg isolate 
4 10 20 30 40 50 60 70 80 90 100 
A C  Y   Y T   Y  
A1 C  Y   Y      
D C  Y Y Y Y Y Y Y Y Y 
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The analysis of the nucleocapsid encoding region in four egg isolates clearly shows that the 
399 bp between nucleotide positions 26729-27130 is highly polymorphic in the case of C 
or T residues (Table 3.17). One of the most polymorphic encoding regions in A isolate was 
identified at nucleotide position 26729 with a minor SNP in ep30 and ep50 and a visible 
SNP at consensus sequence level (T residue) identified in ep70. Further analysis of the A 
isolate Sanger sequenced data confirmed the presence of nine polymorphic nucleotide 
positions identified in more than one egg passage regarding to the C or T residues mixture. 
This data has shown the most variable encoding region at nucleotide position 27060 with 
visible minor SNPs identified within egg passages of A, A1 and C isolate. A high 
frequency of C or T residues was also found at nucleotide position 26887 presenting SNP 
appearance in the A isolate (ep30, ep50, ep70) and D isolate (ep30-50). Further 
investigation of the highly active nucleocapsid encoding region also detected an extra three 
nucleotide positions (26855, 26948 and 26954) with minor SNPs occurring in A and D 
isolate. The analysis of Sanger sequence data identified three nucleotide positions where 
SNPs were visible only once within a 399 bp highly polymorphic region with lack of any 
accumulation in later egg passages of A isolate. Furthermore, the minor SNPs were also 
identified in A1 isolate continued in a few Sanger sequenced egg passages within the 355 
bp highly polymorphic region. The highest activity of C or T residue unique only for A1 
isolate was identified at nucleotide positions: 26888 (ep20-ep80), 26949 (ep40-50) and 
27128 (ep20, ep50). Interestingly, further analyses of the nucleocapsid encoding region 
detected two nucleotide positions 26856 and 26937 with appearance of a C or T residue 
mixture only in ep20 without continuation of SNP accumulation in later egg passages. The 
phenomenon of a SNP appearance relating to an A or C residue mixture at nucleotide 
position 26919 in the A1 isolate (ep60-70) was only detected once at nucleotide position 
26981 of C isolate. 
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Table 3.17. The highly active encoding region of nucleocapsid with majority of C/T 
residue mixture detected in egg isolates. The SNPs found in more than one isolate were 
highlighted as pink.  White = not sequenced, yellow = failure of Sanger sequencing reads, 
orange = minor SNP, red = lack of SNP and green = SNP at consensus sequence level. 
The nucleocapsid encoding region with majority of C or T residue mixture 
Nucleotide Isolate ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
26729 A   Y  Y  T    
26730 A       T Y   
26772 A    Y  Y  Y    
26772 D   Y Y     Y Y       
26773 A1  Y   Y Y Y   Y   
26797 D     Y               
26855 A    Y          
26855 D           Y         
26856 A1  Y               
26887 A    Y  Y  Y    
26887 D     Y Y Y           
26888 A1  Y Y Y Y Y Y  Y   
26891 A Y           Y  
26919 A1          M M     
26936 D                 Y Y 
26937 A1  Y            
26948 A          Y    
26948 D   Y Y Y Y Y Y   Y Y 
26949 A1      Y Y      
26950 C Y Y Y               
26954 A          Y  Y  
26954 D                 Y   
26955 C Y Y Y           Y   
26955 D         Y   Y       
26959 A          Y  Y  
26978 D             Y   Y   
26979 D             Y       
26980 C                   T 
26981 A       Y       
26981 C       M             
26981 D                 Y   
26983 C   Y                 
26987 A    Y        Y  
26994 C                 Y   
27003 C                T Y   
27050 A    Y          
27055 C                 W   
27055 D       Y             
27059 D   Y Y Y Y Y Y Y Y Y 
27060 A Y  Y  Y  Y  Y  
27060 A1  Y   Y   Y    Y    
27060 C Y Y         Y Y Y   
27128 A  Y   Y T    Y  
27128 A1  Y     Y          
27128 D   Y Y Y Y Y Y Y Y Y 
27130 C   Y Y       Y Y Y   
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The analyses of Sanger sequence data identified seven unique C or T residue nucleotide 
positions in the C isolate across a 257 bp polymorphic region, with a variable frequency of 
appearance in different egg passages. High polymorphism was observed at nucleotide 
position 27130 with single accumulation of minor SNP identified in ep20-30 and ep70-90. 
In addition, continuation of SNPs was also investigated at genome positions 26950 (ep10-
30) of the C isolate and 26955 (ep10-30, ep90) in the C isolate and D isolate (ep50, ep70). 
The further analyses of the C isolate genome confirmed the presence of four independent 
minor SNPs identified between nucleotide positions 26889-26994 without further SNP 
accumulation in later egg passages. Interestingly, the analyses of sequence data also 
identified nucleotide positions 26980 (ep100) and 27003 (ep80) with a consensus sequence 
SNP (T residue). In addition, the SNP cluster (C or T residue mixture) of the C isolate was 
also identified with a number of different SNPs in ep90 such as the A or T residues mixture 
such as a nucleotide position 27055. 
 
 The further investigation also confirmed a polymorphism (C or T residue mixture) unique 
for D isolate with various SNP accumulations across analysed egg passages. A clear 
continuation of SNP was visible at nucleotide position 27059 and 27128 in ep20-100 of the 
D isolate. In addition, further investigation of Sanger sequence data also confirmed two 
nucleotide positions where minor SNP (C or T residue mixture) was detected in two egg 
passages at nucleotide position 26936 (ep90-100) and 26978 (ep70 and ep90).  The highly 
polymorphic encoding region was also screened in light of the independent SNPs with 
appearance in one egg passage such as nucleotide positions 26797 (ep30) and 26979 
(ep70). Interestingly, the highly polymorphic region (C or T residue mixture) includes a 
few nucleotide positions previously investigated within A, A1, C and D isolate. In 
addition, the major part of the highly polymorphic region is built up with mutations 
occurring as the independent SNPs across a 399 bp encoding region with further 
continuation as minor SNPs or SNPs at consensus sequence level in two or more egg 
passages.  
 The investigation of the A isolate has shown dynamic SNPs in the viral genome where the 
C or T residue mixture accounted for more than half of total additional SNPs investigated 
in Sanger sequenced data. However, very often egg passages were identified with various 
forms of SNPs including independent SNPs and/or SNP clusters such as ep10 (table 3.18). 
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Table 3.18. The table illustrates the additional polymorphism in a form of independent 
SNPs and SNP clusters in the nucleocapsid encoding region of A isolate indicated to the 
sequence of ep4. Yellow = failure of Sanger sequencing reads, orange = minor SNP, red = 
lack of SNP and green = SNP at consensus sequence level. 
A isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
25926 G       A    
25983 A         M  
25984 G         S  
26012 C     Y Y Y    
26068 C   G        
26086 G   R        
26095 G         R  
26101 G     R      
26111 A   C        
26113 C         T  
26120 A    T       
26126 A   T        
26138 G   A        
26140 C       Y    
26143 NIL   T        
26150 A   T        
26187 A          T 
26194 T          C 
26123 G          T 
26128 G          T 
26235 G R    R      
26269 G       A    
26276 G T          
26277 T A          
26291 C        T   
26298 T       A  Y  
26334 T       A    
26341 T       T    
26364 A           
26403 G R          
26411 G      A     
26450 C       T    
26512 NIL        T   
26527 A     G      
26528 NIL       A    
26551 NIL       A    
26565 T G          
26566 A         G  
26724 C         S  
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 In addition, different egg passages were detected with various levels of polymorphism 
excluding a C or T residue polymorphic region. Interestingly, ep30 was identified as an 
egg passage without independent SNPs, presenting SNP clusters in a form of seven 
consensus sequence SNPs between nucleotide positions 26068-26150 (82 bp) with no 
further continuation in later egg passages. Moreover, a reduced polymorphism was 
analysed in ep40-60 identified with few independent SNPs at consensus sequence level 
comparing to ep70 found with formation of a SNP cluster between nucleotide positions 
26269-26341 (72 bp) and few additional SNPs. Interestingly, ep90 was identified with 
seven SNPs where 85 % of these genomic changes were not accumulated in further egg 
passages. The polymorphism was substantially reduced in ep100 showing no SNPs 
appearing in the C or T residue abundant encoding region or any independent SNPs unique 
for this viral population. However, further investigation showed a SNP cluster between 
nucleotide position 26187-26218 presenting as a formation of four consensus sequence 
SNPs within a 31 bp. The A isolate was identified as having a substantial number of 
independent SNPs without accumulation in later egg passages. In addition, SNP formation 
was shown only twice, presenting the A isolate with reduced accumulation of SNPs within 
a particular egg isolate. 
 
 The identified C or T residue-polymorphic region of the A1 isolate was established to be 
identical as in the A isolate (54 % of all additional SNPs). Interestingly, the SNP cluster 
was identified at consensus sequence level in ep40 between genomic positions 26168-
26198 without any additional independent SNPs in the nucleocapsid encoding region (table 
3.19). The analysed Sanger sequenced egg passages showed only SNPs at nucleotide 
positions 26223 and 26254 in ep50 without formation of a SNP clusters across the viral 
population and lack of any polymorphism in ep60. In addition, a very low polymorphism 
was also confirmed in ep70 presenting a small SNP cluster (three consensus sequence 
SNPs) between nucleotide positions 26674-26684 (10 bp encoding region) separated from 
the nearest minor SNP by 235 bp gap. Further SNP investigation in ep90 could not be 
continued due to the failure of the regular Sanger sequencing reads. However, little 
polymorphism in previous egg passages showed that A1 isolate presented a reduced 
number of SNPs compared to the rest of the egg isolates.   
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 Table 3.19. The table of polymorphism identified as additional SNPs in the nucleocapsid 
encoding region of A1 and D isolate. White = not sequenced, orange = minor SNP, red = 
lack of SNP and green = SNP at consensus sequence level. 
A1 isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
26168 G    C       
26174 G    A       
26184 C    T       
26186 C    T       
26190 T    A       
26196 G    C       
26198 A    G       
26233 C     T      
26254 G     C      
26398 C       Y    
26547 G        A   
26674 G       A    
26680 T       A    
26684 G       T    
D isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
26121 G          R 
26123 A          W 
26174 G        T T  
26175 A        T   
26179 C    A       
26180 C        G   
26181 A        T   
26184 C          A 
26197 T          A 
26210 C          A 
26214 A          T 
26217 A          T 
26218 G          T 
26224 G          T 
26225 C         T T 
26226 C          T 
26228 G    R       
26233 C      Y    T 
26235 G     R      
26241 G          T 
26249 G          T 
26292 C    T       
26342 A   T        
26347 C   Y        
26369 C   T        
26373 NIL     A      
26380 G    A       
26406 NIL    A       
26413 G    A       
26417 G    T       
26577 NIL           
26573 NIL      G     
26580 C     T      
26589 NIL      A     
26603 NIL    T       
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 The SNPs previously not detected in ep110 using 454 pyrosequencing are a substantial 
part of the D isolate showed as a SNP cluster between nucleotide positions 26342-26369 in 
ep30. In addition, SNP accumulation was also confirmed in ep40 (SNP cluster) identified 
at consensus sequence level between nucleotide positions 26292-26417 (125 bp). Further 
analyses of Sanger sequence data confirmed reduced numbers of SNPs in ep50-60, 
presented by consensus sequence and minor SNPs. The ep80 was identified with a SNP 
cluster of four mutations at consensus sequence level between nucleotide positions 26174- 
26181. Interestingly, ep80 showed the first identified genomic change at nucleotide 
position 26174 with further continuation as consensus sequence SNP (T residue) in ep90. 
The most interesting fact is the large number of SNPs presented in ep100 (16 SNPs) 
including SNP cluster (12 SNPs) between nucleotide positions 26184-26249 (65 bp) 
classified as unique for the D isolate, never been seen before in investigated egg isolates. 
Interestingly, all Sanger sequenced SNP clusters were visible only once within its egg 
passage without further continuation. Furthermore, the SNP cluster built up at consensus 
sequence level in ep100 was not confirmed in attenuated ep110 but could have an 
influence on its SNPs accumulation and frequency rate. 
 
 The C isolate clearly showed the unique polymorphism in ep10 identified a SNP cluster 
formed by minor SNPs and SNPs at consensus sequence level between nucleotide 
positions 26048-26184 (136 bp) with the distance of 553 bp to the nearest independent 
SNP  (appendix 13). Furthermore, this same observation was confirmed in ep20 regarding 
to the appearance of two SNP clusters within nucleotide position 26177-26239 (six 
consensus sequence SNPs and one minor SNP) separated by a 278 bp gap from the second 
SNP cluster presenting 10 SNPs between nucleotide positions 26517-26610. Furthermore, 
ep10 and ep20 were analysed as some of the most polymorphic egg passages shown by 
unique and independent SNPs (A or T residue mixture) occurring as the most common 
mutations. Interestingly, a common characteristic relating to the appearance of close 
mutations were also shared between ep30 and ep40 showing a SNP cluster (six residues) 
found between nucleotide position 26179-26198 (ep30) and nucleotide position 26052-
26108 (ep40). The accumulation of SNPs was also confirmed in ep60 identified with a 
highly polymorphic encoding region formed by 21 SNPs between nucleotide positions 
26039-26104 (56 bp) with no additional independent SNPs. The same situation was 
presented in ep70 with two highly polymorphic encoding regions, 22 SNPs identified 
between nucleotide positions 26051-26167 (116 bp) and 20 SNPs found between 
87 
 
 
nucleotide positions 26725-26810 (85 bp) across the investigated viral population. Further 
analyses showed the distance between these two clusters as 558 bp proving no correlation 
between two highly polymorphic regions of ep70.  The further investigation of ep80 has 
shown common characteristic to have a mixture of SNPs at consensus sequence level 
within a short bp length presented by two SNP clusters  between nucleotide positions  
26170- 26198 (28 bp) and  26683-26720 (37 bp). Further analyses also confirmed 
consensus sequence SNPs in the SNP cluster of ep90 between nucleotide positions 26083-
26195 which in fact fully overlaps with the first SNP cluster of ep80 in the C isolate. 
Interestingly, ep100 could not be confirmed with a presence of SNP clusters but was 
identified with a number of unique SNPs across the viral population.  
 
3.5.10 The summary of polymorphism in nucleocapsid encoding region 
 
 
 
Figure 3.7. The total number of SNPs across all investigated egg isolates in nucleocapsid 
encoding region with the final reads of ep110 (>5 % freq.). The diagram presents number 
of genomic mutations in each of analysed egg passage (ep10-110). The bar chart illustrates 
polymorphism across four egg isolates (A, A1, C and D isolate) presented by different 
colours. The table below bar chart presents exact number of SNPs identified in egg passage 
and egg isolate of interest.  
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 The nucleocapsid encoding region was identified with the highest number of SNPs in all 
investigated egg isolates. Interestingly the pattern of SNP accumulation was found similar 
to the S2 subunit (part 1) where SNPs were visible in ep10-50 without rapid increasing of 
genomic mutations. However, C isolate presents high polymorphism in ep10-20 with 
maximum of 27 SNPs identified using Sanger sequencing. Interestingly, the number of 
SNPs rapidly decrease in ep30-ep50 to reach the highest number of identified SNPs in 
ep70 (45 SNPs) and reduced again with final result of 12 SNPs in ep100 (figure 3.7). The 
similar observation was made in Sanger sequenced data of A isolate with the highest 
number of SNPs (31) in ep70. However, A isolate has shown visible accumulation but also 
reduction of SNPs every 20 egg passages. The further analyses of Sanger sequenced data 
highlighted phenomenon similar to observations made within S2 subunit of A and D 
isolate. The SNP accumulation in nucleocapsid encoding region of A and C isolates 
increase or decrease in opposite manners between ep20-50 with two increased 
accumulation of SNPs in ep70 and ep90. Interestingly, SNP accumulation in A1 and D 
isolate was observed with a pattern with minimal polymorphism in ep10 and gradual 
reduction of genomic mutations from ep40 to ep80. Interestingly ep80 is a crucial point 
where SNP accumulation increases in D isolate from 14 SNPs (ep80) to 26 SNPs (ep100) 
but decreases in A1 isolate with final result of one SNP in ep100. Interestingly, reduced 
polymorphism in ep90-100 of A, A1 and C isolates did not have an influence on SNPs 
measurement in ep110 comparing to increasing polymorphism in ep90-100 of D isolate. 
Furthermore, analyses of pyrosequencing data (ep110) has shown increased number of 
SNPs in A and A1 isolates but decreasing tendency in C and D isolates comparing to 
polymorphism found in ep100.  
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3.5.11 The analyses of polymorphism observed across all genes. 
 
 
Figure 3.8. The bar chart presents the total sum of SNPs identified within four egg isolates 
in Sanger sequenced encoding regions including >5 % frequency of pyrosequenced 
datasets.  The bars were presented as follow: blue = S1 subunit, red = S2 subunit and green 
= nucleocapsid. The table below bar chart includes the exact number of SNPs identified in 
each egg passage of analysed encoding region. The zero numbers marked as red colour 
relates to failure of Sanger sequencing reads.  
 
 The Sanger sequenced data showed the scale of total SNP accumulation in previous egg 
passages within three encoding regions at >5 % frequency. The figure 3.8 presents visible 
pattern of polymorphism between S1 subunit and nucleocapsid encoding region. Both 
genes were found with number of investigated SNPs in ep10-20 showing increasing SNP 
accumulation in nucleocapsid (49 SNPs) and S1 subunit (13 SNPs) at >5 % frequency. 
However, ep30 was found as the crucial point showing decreasing polymorphism in S1 
subunit (five SNPs) and increasing number of SNPs in nucleocapsid (54 SNPs). Further 
analyses of previous egg passages also identified ep50 and ep70 as the breaking points 
presenting nucleocapsid encoding region and S1 subunit with opposite tendency of SNP 
accumulation in viral genome. According to the results included in bar chart above, ep50 in 
nucleocapsid was classified with a relatively high number of mutations (45 SNPs) but with 
increasing SNP tendency in further egg passages and maximum of 98 SNPs identified in 
ep70. Interestingly, ep70 in S1 subunit was identified as one of the lowest points in SNPs 
accumulation presenting only seven mutations. However, the extreme difference in SNP 
accumulation visible in ep70 between S1 subunit and nucleocapsid led to another 
interesting situation. The analysed Sanger sequenced data has shown increasing number of 
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SNPs in S1 subunit (25 SNPs) and nucleocapsid (68 SNPs) in ep90 and decreased SNP 
accumulation in ep100 classified as six SNPs in S1 subunit and 29 SNPs in nucleocapsid 
encoding region. Interestingly, S2 subunit was found with visible SNP accumulation in 
early egg passages presenting a maximum of 16 SNPs in ep20. Further investigation of 
Sanger sequenced data identified increased polymorphism in ep70 presented by 26 
mutations with decreasing SNP accumulation in ep80-100. Interestingly, deep sequenced 
data presented increased number of SNPs in ep110 at >5 % frequency presented final value 
of six SNPs (S1subunit) and nine SNPs (S2 subunit). However, significant accumulation of 
mutations in nucleocapsid encoding region identified in Sanger sequenced egg passages 
was reduced to 29SNPs found in pyrosequencing data of ep110 at >5 % frequency. The 
reduction of polymorphism in ep110 can be possibly explained by selection of SNPs which 
play a key role in process of attenuation under lack of immune pressure. This observation 
was present in all encoding regions of interest showing that reduction of viral 
pathogenicity could possibly depends on few genomic changes across viral quasispecies. 
 
 
 
Figure 3.9. The bar chart illustrates the accumulation of SNPs found at >50 % frequency 
in ep110  also visible across Sanger sequenced egg passages. The bars were presented as 
follow: blue = S1 subunit, red = S2 subunit and green = nucleocapsid. The table below bar 
chart includes the exact number of SNPs identified in each egg passage of analysed 
encoding region. 
 
 Figure 3.9 shows the significant level of >50 % frequency SNPs accumulation in later egg 
passages of S1 subunit, S2 subunit and nucleocapsid encoding region. The Sanger 
sequence datasets presented very low polymorphism in early egg passages with maximum 
ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 ep110
S1 subunit 0 0 0 0 2 1 1 2 2 1 4
S2 subunit 0 0 0 0 1 1 3 3 2 1 9
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of one SNP as seen in ep10-40. The number of mutations at >50 % frequency were 
observed with gradual accumulation in ep80 within three encoding regions with the highest 
activity observed in nucleocapsid (four SNPs). In addition, the polymorphism in 
nucleocapsid encoding region seems to be continued with the maximum measurement of 
seven SNPs in ep90. Figure 3.9 also presents a very similar pattern of SNP accumulation 
and reduction in S1 and S2 subunits which starts in ep50 (one SNP) followed by increasing 
number of mutation at maximum point of three SNPs in S2 subunit (ep80) and progressive 
reduction visible in ep100 (one SNP) of both spike subunits.  In addition, S1 and S2 
subunits were identified with SNPs accumulation at this same level in ep60 (one SNP) and 
ep90 (two SNPs).Interestingly, all three encoding regions were also found with decreasing 
number of SNPs in ep100 before the final pyrosequencing reads in ep110 at >50 % 
frequency. Interestingly, the lower number of polymorphisms in ep100 did not mirror the 
situation of SNP accumulation in ep110 presented with nine SNPs observed in S2 subunit, 
eight SNPs in nucleocapsid and four SNPs found in S1 subunit. 
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Chapter 4: Discussion 
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4.1   Introduction 
 
 The final confirmation of pathogenicity loss in egg isolates was confirmed after infecting 
Rhode Island Red chickens, identified with lack of any post-infection clinical signs. The 
analyses of sequenced data from 110 egg passages showed build-up of SNPs in the 
nucleocapsid and spike encoding regions which might be involved in the attenuation of the 
four egg isolates. Further investigation showed a number of SNPs commonly visible within 
more than one egg isolate. In addition, appearance of these SNPs was identified at different 
stages of egg passage depending on the analysed isolate and SNP frequency in ep110. 
Furthermore, the appearance of additional SNPs previously not detected in ep110 was also 
confirmed as a substantial part of the investigation. These findings have clearly shown the 
viral genome as a dynamic environment which, in the absence of immune pressure presents 
a mixed formation of SNP clusters and independent SNPs within particular egg passages. 
In addition, SNP accumulation within egg passages is not a phenomenon visible in all 
investigated egg isolates suggesting the influence of numerous factors affecting the 
polymorphism. 
 
4.2     Verification of vaccine efficiency based on animal testing 
 
 One of the most effective ways to confirm the loss of viral pathogenicity is infecting birds 
with multiple egg passaged viral agent. In this case, the attenuation was confirmed after 
infecting four birds only (Rhode Island Red chickens) for each isolate. This methodology 
is commonly used for production of many poultry vaccines based on live-attenuated 
vaccine strains. According to results of viral attenuation verification, 110 passages were 
required to achieve a virus strain to become attenuated sufficiently to comply with safety 
requirements for live IB vaccines. So far, the types of mechanism causing a virus to 
attenuate are not fully recognised. However, the investigation of SNPs accumulated during 
multiple egg passages identified potential SNPs which are probably involved in loss of 
viral pathogenicity. Hung and Wang, 2007 has confirmed presence of genomic mutations 
(SNPs) in QX-like infectious bronchitis virus strain after only 80 egg passages in the spike 
1 and 2 subunits after sequencing the 3’ 7.3 kb of the genome of an attenuated and parent 
virus strain from which an attenuated strain was derived. However, there was lack of any 
SNPs identified in the nucleocapsid but the envelope protein and the membrane protein. 
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This information confirms that the attenuation process and the encoding region involved 
strongly depend on IBV strain and the number of egg passages required for loss of 
pathogenicity. 
 
 Geerligs et al., 2011 confirmed a clear effect of increased egg passage level on the results 
of ciliostasis scores which decreased after 25 passages. Interestingly, the results of 
ciliostasis increased again until ep 50 with constant reduction straight after. These results 
clearly demonstrate that the IBV isolate was attenuated during passaging and the data for 
passage level 80 can be considered with respect to safety for the respiratory tract and 
kidneys of tested birds. Interestingly, investigation of viral attenuation (Crinion & Hofstad, 
1971) also confirmed 12.5% female chickens with lesions in the oviducts on the day of 
hatching. IBV caused lesions only in chickens vaccinated at 1 day of age, but no lesions 
were found in chickens vaccinated at 8 days of age. These data confirm finding in the egg 
passages of M41 strain investigated in the Pirbright Institute. The evidence of attenuation 
after infecting Rhode Island Red chickens clearly shows the presence of virus in trachea 
followed by lack of post-infection clinical signs on day 3-7. 
  
 The universal live vaccines against constantly emerging IBV strains do not yet exist. In 
order to find ways to protect poultry against IBV strains, combinations of existing vaccine 
strains have been tested using birds. The results of that practice showed that combined 
vaccines could possibly confer protection against newly IBV strains challenge. The 
disadvantage of this practice is the case of accidental production of more pathogenic 
strains mutated from existing IBV agents (Hopkins & Yoder, 1984). Luckily, it is not 
unusual for chickens to be vaccinated with different combinations of vaccines to generate 
broad protection. Other aspects, such as degree of attenuation and interactions and 
compatibilities with other vaccines, also should be taken into account (Terregino et al., 
2008). 
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4.3    The failure of Sanger sequencing assay in previous egg passages 
 
 The failure of Sanger sequencing reads was a significant issue in investigation of 
polymorphism in a number of previous egg passages including S1 subunit, S2 subunit 
(part1), and S2 subunit (part2) encoding regions regarding to four egg isolates. The cDNA 
synthesis was a problem in successfully obtaining complete Sanger sequencing data due to 
inappropriate heating of the sample to 65 oC for five minutes and incubating them on ice 
for at least one minute. However, this issue was solved successfully with visible bands on 
agarose gel after the amplification process of cDNA samples, synthesized once again. 
Furthermore, purification of samples was done by using GFX PCR, DNA and Gel Band 
Purification Kit or PCR product purification (Qiagen QIAquick Spin Handbook) following 
the instructions from the manual. Interestingly, the purification process was only partially 
successful showing ethanol contamination of S1 subunit samples based on 260/230 ratio 
identified as the main issue in Sanger sequencing assay presenting low bars throughput of 
A isolate (ep40, ep60-100), A1 isolate (ep10-40), C isolate (ep10, ep30, ep50, ep70, 
ep100) and D isolate (ep10-30, ep80). Sometimes the Sanger sequencing reads (S2 
subunit–part1) were visible but the signal stopped abruptly showing a secondary structure 
(GC and AT rich templates caused the DNA to loop and form hairpins) causing failure of 
Sanger sequence reads in A isolate (ep10), A1 isolate (ep10, ep80 and ep100), C isolate 
(ep10, ep30-100) and D isolate (ep10 and ep30). The designed primers were only a 
problem in S2 subunit (part2) encoding region due to no priming site present in the viral 
genome but also primer dimer formation. Moreover, failure of S2 subunit (part 2) Sanger 
sequencing was identified as a main issue in completion of polymorphism in previous egg 
passages followed by satisfactory amplification of S1 subunit, S2 subunit (part1). 
Interestingly, nucleocapsid encoding region was successfully Sanger sequenced in all egg 
passages of four egg isolates comparing to S1 and S2 subunit (part1). 
 
4.4    The cases of overlapping SNPs in investigated IBV encoding regions 
 
 SNPs identified at the same nucleotide position in all investigated egg isolates might 
indicate a substantial influence on viral attenuation. Interestingly, the spike encoding 
region presented SNPs at common nucleotide positions in a maximum of three egg isolates 
identified as non-synonymous (S1subunit) and synonymous (S2 subunit) mutations. The 
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S1 subunit is responsible for viral neutralisation, attachment to the host cell but also viral 
pathogenicity. Therefore, substantial SNPs in the spike encoding region may be correlated 
with the viral attenuation. In addition, the identified SNPs in both subunits were found with 
a high frequency (>50 %) in ep110 suggesting a strong influence of polymorphism within 
the viral population. Furthermore, the high SNP frequency (80 %) in ep4 (unknown level 
of pathogenicity) showed no correlation with increasing SNP frequency in ep110 but had 
an impact on SNP accumulation in Sanger sequenced egg passages. In addition, S1 subunit 
was also found with only one synonymous SNP (1.1-1.7 % freq.) within three egg isolates 
compared to S2 subunit identified with three synonymous SNPs (52-98 % freq.) suggesting 
visible differences in genome changes within two subunits of spike encoding region. 
However, it is reasonable to conclude that only a small fraction of SNPs are crucial for 
attenuation of pathogenicity. Therefore, the differences in SNP accumulation within the 
spike encoding region of the four egg isolates suggested that the attenuation process is 
driven by many forces and might be possible due to SNP accumulation in other encoding 
regions.  
 
 A high number of overlapping SNPs was also identified within the nucleocapsid encoding 
region with two SNPs commonly visible within three and four egg isolates suggesting a 
substantial influence of nucleocapsid in the process of building up the attenuated egg 
isolates. Interestingly, shared SNPs were identified in all cases with a relatively low SNP  
frequency (<50 %) in ep110 suggesting involvement of the nucleocapsid in early stages of 
viral attenuation, developing in a small fraction of the viral population and having an 
impact on the further appearance of SNPs in the spike encoding region.  In addition, these 
sequence datasets have shown a correlation between SNPs in previous egg passages and 
SNP frequency in ep110. Furthermore, sometimes a lower frequency (>17 %) was 
identified as having a substantial SNP accumulation in previous egg passages compared to 
SNPs at >50 % frequency in ep110 without further signs of SNPs activity in Sanger 
sequenced egg passages. The analyses of deep sequence data confirmed that SNP 
appearance in single genome positions could be a random phenomenon clearly visible with 
a low frequency in ep110. Therefore, SNPs should be carefully identified as an early sign 
of the attenuation process leading to a substantial impact on viral pathogenicity. Similar to 
the spike, the nucleocapsid encoding region was identified as having only two common 
synonymous SNPs with a frequency of 31-33 % (ep4) and 20-43 % (ep110) within the 
investigated egg isolates. This phenomenon might be a sign presenting influence of 
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synonymous SNPs in the attenuation process occurring in four egg isolates after multiple 
egg passages. In addition, research studies suggested that synonymous SNPs exempt from 
functional constraints at the protein level, and its rate reflects the mutation rate to a great 
extent especially in the light of non-synonymous changes across viral genome. The 
variation of SNPs identified in four egg isolates could be caused by different replication 
frequencies, which are affected strongly by the infection and transmission mode in 
embryonated chicken eggs (Hanada et al., 2004). Interestingly, common SNPs identified in 
the nucleocapsid encoding region were less visible in previous egg passages compared to 
SNPs detected in the spike encoding region potentially due to the low SNP frequency in 
ep110 (nucleotide position 26791) showing reduced polymorphism. Furthermore, the 
synonymous SNP analysed at nucleotide position 26793 in all four egg isolates presented 
an activity which might have an impact on SNP appearance in a neighbouring nucleotide 
position 26792 in the viral populations of A, A1, C and D isolate. However, the situation of 
genomic changes identified in extreme close locations was found only once in the 
nucleocapsid without further explanation or any confirmation relating to the spike 
encoding region.  
 
 Further investigation also classified a number of overlapping SNPs previously not 
detected by the 454 pyrosequencing reads in ep110. Interestingly, there is a lack of 
overlapping SNPs in the case of the S1 subunit showing this highly active encoding region 
without common SNPs in four egg isolates. However, the S2 subunit was defined as a 
more conserved part of the spike encoding region responsible for virus to cell and cell to 
cell fusion. Interestingly, analysed Sanger sequence data showed a highly polymorphic 
encoding region within the first 892 bp of S2 subunit with substantial SNP correlation in 
the A, C and D isolate at eight nucleotide positions identified as independent SNPs. 
However, the analyses also classified a number of SNPs such as nucleotide position 22224 
visible as polymorphic across investigated egg passages of C and D isolate. Furthermore, 
the majority of SNPs might indicate that the attenuation process could be dependent on a 
selection of minor SNPs within the viral population resulting in a reduction of 
pathogenicity in quasispecies. Similar to the identified number of SNPs in ep110, the 
highest numbers of additional SNPs shown by Sanger sequencing were detected in the A 
isolate. These findings showed the influence of additional SNPs which might be crucial in 
building up the attenuation process observed in four egg isolates. 
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4.5    The influence of differences between SNP frequency in ep4 and ep110 
 
 The low SNP frequency of ep4 seems to have an influence on SNPs and their frequency at 
the consensus sequence level in ep110 but also the SNPs appearance in the Sanger 
sequenced egg passages. The confirmation of above statement was identified in 
nucleocapsid encoding region where SNP accumulation was strongly dependent on the 
changes in frequency between ep4 and ep110. In addition, in most of the cases the 
relatively reduced (<30 %) SNP frequency in ep4 was continued in all egg isolates 
resulting in a lower (<29 %) frequency of ep110 having also an influence on SNP 
accumulation in Sanger sequenced egg passages. This phenomenon was observed at 
nucleotide positions 26792 and 26793 where the dynamics of SNP accumulation were not 
predictable showing relatively low SNP frequency in ep4 followed by SNP accumulation 
in all egg passages which could be a sign of the attenuation process. However, the low 
frequency (>43 %) identified in ep110 after the appearance of SNPs at consensus sequence 
level in previous egg passages (nucleotide position 26792-26793) might be due to potential 
error in 454 pyrosequenced data caused by poly A tract present in viral genome. This issue 
could be solved by Sanger sequencing of nucleocapsid encoding region to analyse 
nucleotide position 26792-26793 in order to confirm polymorphism in viral genome.  
Interestingly, the A1 isolate presents polymorphism only in ep70-90 (nucleotide position 
26792) which could be triggered by other factors (undefined yet) influencing the SNP 
appearance in later egg passages. The lower frequency in ep4 followed by SNP 
accumulation in all Sanger sequenced egg passages could be a sign of selection the random 
SNPs across the viral population. In addition, the further observation confirmed the link 
between the SNP frequency in ep4 and its substantial impact on SNP appearance in early 
egg passages and the final measurement of SNP frequency in ep110. The reason might be 
the low SNP accumulation in the viral population which could not be continued further as 
a selection of minor SNPs but also the fact of less sensitive detection of mutation by 
Sanger sequencing comparing to deep sequencing method. This observation was confirmed 
with very low but increasing frequency between ep4 (2.6 %) and ep110 (8.6 %) identified 
at nucleotide position 26791 in D isolate with lack of any polymorphism in Sanger 
sequenced egg passages. Interestingly, further investigation also identified the C and D 
isolate (nucleotide position 26795) with a low (15 %) frequency in ep4 leading to a higher 
(23-36 %) frequency in ep110 without sign of SNPs activity in previous egg passages. The 
observation of constantly changing frequency between ep4 and ep110 has shown no 
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correlation in appearance of SNPs in viral genome of Sanger sequenced egg passages. 
Further investigation, also confirmed no influence of polymorphism in previous egg 
passages with increasing SNP frequency between ep4 and ep110. The results of 
investigation have shown the dynamics of viral genome after numerous egg passages 
which might have a place due to lack of immune pressure in embryonated chicken eggs. 
 
4.6    The SNPs potentially involved in process of attenuation 
 
 Based on the information analysed from deep sequence data, the process of attenuation 
seems to have different mechanisms of formation in egg isolates. The SNPs found at 
consensus sequence level might be involved in loss of virulence due to appearance in more 
than 50 % of viral population. Interestingly, none of investigated encoding regions have 
showed genomic changes shared within four egg isolates after multiple egg passages at 
>50 % frequency in ep110. Interestingly, S1 subunit as the highly polymorphic part of 
spike encoding region was found with non-synonymous SNP shared within three egg 
isolates. In addition, S2 subunit identified as highly mutative under lack of immune 
pressure presented three synonymous genomic changes visible in two egg isolates at 
consensus sequence level. This observation might indicate the significant influence of 
spike as encoding region implying in process of attenuation. It is understandable that non-
synonymous genomic changes will have a greater impact on viral virulence due to possible 
changes in amino acid sequence. However, it is believed that synonymous SNPs might 
have an influence on further genomic changes leading to loss of virulence in egg isolates 
(Studer et al., 2013). Furthermore, the SNP rate at nonsynonymous sites is roughly 100-
fold less than that at synonymous sites in RNA viruses although the greater influence of 
natural selection at synonymous sites is likely to increase the variance in viral genome by 
appearance of non-synonymous SNPs (Holmes, 2003). Therefore, all SNPs identified at 
>50 % frequency in ep110 must be consider as potential key mutations responsible for 
driving the process of attenuation under lack of immune pressure.  Further analyses of 454 
pyrosequencing datasets clearly shows fundamental meaning of unique SNPs at consensus 
sequence level classified in each egg isolate as mutations potentially involved in key 
genomic changes after multiple egg passages. The spike and nucleocapsid encoding 
regions were also identified within four encoding regions with the highest percentage of 
unique SNPs classified at >50 % frequency. However, there is no evidence as to how many 
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SNPs (non-synonymous and/or synonymous) are required for successful attenuation and 
loss of virulence in investigated egg isolates. In addition, the nucleocapsid has shown twice 
the number of >50 % frequency SNPs comparing to spike encoding region which might 
play a crucial role in loss of virulence within four egg isolates. Interestingly, none of these 
SNPs were shared in more than one isolate which partially explains the complicated 
mechanism responsible of attenuation process. In addition, spike encoding region also has 
shown few SNPs identified as unique for particular egg isolate suggesting induction of 
severe changes in analysed viral population structure.  Therefore, constantly changing 
situation in viral genome after multiple egg passages can go in many different directions 
leading to this same conclusion and final attenuation in major part of viral population. 
 
 Interestingly, loss of virulence can be trigger by appearance of SNPs with >5 % frequency 
which by “domino effect” might cause another genomic changes in viral population. The 
above hypothesis is supported by the results of deep sequence data analysed in 
nucleocapsid encoding region found with two SNPs shared within four egg isolates at >5 
% frequency. In addition, significantly lower frequency within viral population has shown 
SNPs which are also shared within three egg isolates in nucleocapsid encoding region. It is 
believed that appearance of mutations in a small fraction of larger viral quasispecies might 
have an influence on development of genomic changes which at some point will be 
classified at consensus sequence level. This situation had a place in spike encoding region 
where shared >5% frequency SNPs were present in deep sequenced analyses of >50 % 
frequency SNPs in ep110. Interestingly, further investigation has shown that above 
situation was confirmed only in a case of spike encoding region, whereas other encoding 
regions were classified with decreasing number of SNPs regarding to gradual increasing in 
frequency. The attenuation process followed by loss of virulence might begin in shared 
polymorphic genome positions at extremely low SNP frequency (<5 %) within three egg 
isolates as showed in S1 subunit. However, there is no evidence or confirmed link between 
attenuation process and genomic changes investigated in 1-5 % of viral quasispecies. 
Therefore, SNPs at <5 % frequency identified using 454 pyrosequencing data were 
included in deep sequenced datasets but not considered as crucial in process of attenuation 
under lack of immune pressure. 
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4.7    The different stages of SNP accumulation in investigated egg isolates 
 
 The four egg isolates were identified with a substantial SNPs accumulation in early and/or 
later egg passages using Sanger sequencing. Further analyses had indicated that SNP 
appearance in egg passages strongly depended on the egg isolate but also the encoding 
region of interest. The identification of SNPs in the S1 subunit clearly showed the SNP 
accumulation at consensus sequence level in early egg passages of the A (data available 
only for ep10-50). Further observation identified SNPs which were present in early egg 
passages without information about further continuation (A isolate - data not available) 
suggesting that SNPs occur at consensus sequence level but their continuation varies in egg 
isolates. Interestingly, the visible SNPs within a single egg passage could be spotted as a 
part of SNP cluster which, in the absence of immune pressure, were not continued as 
independent mutations in later egg passages. However, Sanger sequenced data has shown 
A1 (no data for ep20-40) and D isolate with very low SNP activity in early egg passages 
but the presence of minor SNPs and/or SNPs at consensus sequence level in later egg 
passages. Interestingly, C isolate has shown a large number of minor SNPs and SNPs at 
consensus sequence level appearing independently or in SNP clusters across all Sanger 
sequenced egg passages. Its seems that the increased activity of mutations occur in the 
viral genome across investigated egg passages make a significant impact on the attenuation 
process presenting C isolate as the most attenuated egg isolate. These data suggest that the 
SNP accumulation under lack of immune pressure have significant effect on level of 
attenuation and the way in which particular egg isolate lost its virulence. In addition, the 
high SNP frequency at genomic positions in ep110 seems to be necessary for the process 
of attenuation but selection of those SNPs has been shown as random or driven by other 
factors responsible for lack of viral pathogenicity. Furthermore, the viral populations were 
also identified with a visible continuation of fewer minor SNPs which graduated to SNPs 
at consensus sequence level suggesting that the attenuation in quasispecies might be due to 
progressive SNP accumulation visible in Sanger sequenced egg passages. Interestingly, 
this idea can be accepted by the SNP examples found in the S1 subunit of the A and A1 
isolate showing the early egg passages as an accumulation of minor SNPs with a change to 
SNP at consensus sequence level in later egg passages and a strong SNP frequency (≥99 
%) in ep110.  
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 Interestingly, the observation of SNP appearance in the S1 subunit was also confirmed in 
the S2 subunit (part 1) relating to various levels of SNP accumulation as potentially key for 
investigating the attenuation process in egg isolates. In addition, the mechanism of slow 
selection of the mutations was confirmed in the A isolate as a synonymous SNPs clearly 
visible only in later egg passages. However, the identification of progressive SNPs could 
be confirmed in the S2 subunit with a high SNP frequency (>52 %) in ep110 having an 
influence on SNPs accumulation  visible as  minor SNPs in previous egg passages (ep30-
70) and SNPs at consensus sequence level in ep80-90 of A isolate. Interestingly, 
polymorphism found in the D isolate confirmed the fact of viral genome described as 
highly dynamic environment  with the SNP accumulation identified as minor SNP in early 
egg passages which turns back to the original nucleotide from ep4 in ep70-80 of the S2 
subunit (part 1) with the final 56 % SNP frequency in ep110.  These differences of SNPs 
appearance with the high frequency within two egg isolates suggest that the polymorphism 
in viral genome strongly depends on many other factors which in the lack of immune 
pressure present selection of minor SNPs. In addition, process of attenuation might be 
successful due to the combination of unique and commonly found SNPs in the viral 
genome after 110 egg passages. Interestingly, not all investigated egg isolates were 
identified with visible additional SNPs and their continuation in egg passages potentially 
having an influence on the attenuation process. However, this phenomenon was observed 
few times in the case of the S1 and S2 subunit (part 1) suggesting a substantial change in 
SNP occurrence during selection of minor SNPs in the spike encoding region. The 
dynamics of SNP accumulation has shown as a difference within investigated egg isolates 
supported by number of SNPs and the degree of continuation within the viral populations. 
The A and D isolate were identified with various lengths of SNP accumulation across 
Sanger sequenced egg passages supporting the idea of SNP selection continued in later egg 
passages. Further investigation identified two nucleotide positions in both egg isolates with 
SNPs (mixture of C or T residues and A or G residues) detected in ep30-80. The SNP 
accumulation was also confirmed as a substantial part of the A1 isolate with more specific 
selection of minor SNPs in the viral genome compared to the A and D isolate where 
Sanger sequence data indicated SNP accumulation in fewer egg passages but at consensus 
sequence level.   
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 The highly polymorphic encoding region of the nucleocapsid was investigated in light of 
SNP accumulation and the differences relating to selection of SNPs in the viral population 
of ep110. The analyses of Sanger sequence data clearly showed that the nucleocapsid 
encoding region presented different types of SNP accumulation previously identified in the 
spike encoding region such as graduate SNP accumulation and the appearance of 
independent SNPs without a further continuation in later egg passages. The nucleocapsid is 
known as highly conserved in nature compared to the nucleocapsid of egg isolates found 
with the great polymorphism (Schelle et al., 2005). Interestingly, the majority of SNPs 
were identified with further continuation due to SNP appearance at consensus sequence 
level in later egg passages. This phenomenon could be observed in each of the investigated 
egg isolates with a difference in the number of egg passages required for SNP visibility in 
a major part of the viral population. Further Sanger sequencing showed that the A isolate 
was generally identified with SNP accumulation in early egg passages and its continuation 
as the consensus sequence SNP in later egg passages. However, in some cases the SNPs 
were observed among egg passages without further identification in later egg passages 
before a final appearance in ep110 of the A and D isolate. However, the majority of SNPs 
with further accumulation have been shown at consensus sequence level with relatively 
high frequency in ep110 (>50 %) as seen in the nucleocapsid encoding region of the A1 
isolate. The SNP dynamics in viral population presents different levels of SNP 
accumulation in all four egg isolates. Furthermore, a high frequency (>98 %) in ep110 
seems to have an impact on SNP accumulation in Sanger sequenced egg passages with 
further identification as SNPs at consensus sequence level in the ep110. However, a lower 
frequency (<20 %) did not show a substantial impact on the appearance of consensus 
sequence SNPs and their continuation. In addition, the nucleocapsid encoding region was 
identified as a logical SNP accumulation in numerous egg passages of A1 and D isolate, 
also detected in A and C isolate as independent SNPs. These data suggest that a lack of 
immune pressure in embryonated chicken eggs is not the only one force involved in 
building up viral attenuation. Further investigation of the viral genome after 110 egg 
passages might indicate the influence of independent SNPs or SNP clusters which could 
cause further polymorphism in nucleocapsid encoding region.   
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4.8    The unique SNP cluster identified in the nucleocapsid encoding region 
 
 An interesting SNP accumulation was also detected in a part of the nucleocapsid encoding 
region identified as minor SNPs (C or T residues) visible at numerous nucleotide positions 
in many egg passages of four egg isolates. The appearance of multiple SNPs within 
relatively short encoding region in egg isolates (241-399 bp) is believed to have an 
influence on nucleocapsid polymorphism in the viral populations. These findings might 
suggest that the substantial SNPs in the nucleocapsid encoding region might alter the 
independent SNP appearance under lack of immune pressure in rest of nucleocapsid and 
the spike encoding regions due to changes of amino acid composition and /or alteration of 
the reading frames. The high polymorphism of C or T residues in all investigated egg 
isolates could be responsible for selection of the SNPs which were successfully continued 
in later egg passages. Furthermore, the most visible SNP accumulation of C or T residues 
was identified in the A (17 SNPs) and D (14 SNPs) isolate with relatively high detection 
rates compared to other SNPs within C or T residue abundant encoding region which might 
be an effect of substantial SNPs activity relating to lack of immune pressure. Furthermore, 
this theory seems to make sense after identification of the same highly polymorphic 
encoding region confirmed in the A1 isolate (eight SNPs) and the C isolate (11 SNPs) as C 
or T residue mixture. These differences in the level of diversity among SNP clusters in the 
egg isolates could be explained as a random accumulation of minor SNPs without a logical 
pattern or explanation. In addition, further investigation confirmed a correlation between 
appearances of C or T residue in a single or multiple egg passages within the four egg 
isolates. The percentage of these SNPs escalated to around 40 % in the case of continued 
SNPs and 60 % as independent SNPs (A and D isolate). The situation changed completely 
in the A1 isolate showing 75% of SNPs as continuing and 25 % as independent SNPs. 
According to these analysed sequence data the C isolate was also found with 27 % of 
continued SNPs and 63 % of independent SNPs. These differences might be due to 
independently passaged viral populations in embryonated chicken eggs resulting in various 
numbers of independent or continued SNPs. Further analyses of Sanger sequence data also 
presented various degrees of C or T residue mixture accumulation in egg passages among 
quasispecies having a potential impact on final SNP appearance in ep110 and its SNP 
frequency. Furthermore, the nucleotide positions 27059 and 27128 were found as an 
exception where SNP accumulation of C or T residues was observed in all egg passages of 
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the D isolate suggesting that the viral genome can be defined as a highly active SNP 
environment. 
 
4.9     The SNP clusters and/ or independent SNPs within one isolate 
 
 The phenomenon of a highly polymorphic encoding region (C or T residue mixture) 
clearly visible in the form of SNP accumulation was identified in the nucleocapsid 
encoding region within the Sanger sequenced egg passages of the A, A1, C and D isolate. 
Interestingly, dynamics of SNPs (C or T residue mixture) were identified as random event 
due to a substantial number of all additional SNPs (50 %) in viral populations occurring 
without logical pattern across nucleocapsid encoding region. Furthermore, the absence of 
immune pressure in embryonated chicken eggs could have an influence in the form of a 
rapid response presenting a large number of independent SNPs in the viral genome visible 
in the early stages of Sanger sequenced egg passages across the spike and nucleocapsid 
encoding regions. In addition, some viral populations were identified with a low 
polymorphism in early egg passages such as C isolate showing that a single stranded RNA 
viral genome might alter by SNP accumulation during later egg passages screened by 
regular Sanger sequencing (Rafiei et al., 2009). Therefore, SNP appearance in the form of 
SNP clusters or independent SNPs in later egg passages could be a sign of slower 
adaptation within the viral population relating to absence of immune pressure. 
Interestingly, the presence of SNP clusters within egg passages were detected in all four 
egg isolates and could be a different way of selection the minor SNPs, possibly continued 
by accumulation of single SNPs visible in a form of the C or T residue mixture. Further 
observations showed the same ability in the nucleocapsid encoding region of the C isolate 
where overlapping SNP clusters were observed between ep60-70 and also ep80-90. The 
analysis of Sanger sequenced data showed that formation of SNP clusters might be due to 
selection of the one or two minor SNPs which are shared within a number of egg passages.  
 
 Furthermore, S2 subunit of A isolate showed the appearance of SNP formations which 
might be triggered by the accumulation of independent SNPs continued in Sanger 
sequenced egg passages which at some point caused more polymorphism within 
neighbouring nucleotide positions in a particular egg passage. Interestingly, the formation 
of SNP clusters is not always caused by the further continuation of SNPs presented in 
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polymorphic encoding regions. The further analysis of Sanger sequence data also identified 
a large number of independent SNPs which are not associated with the presence of SNP 
clusters in single egg passages but presents a various degree of SNP accumulation with or 
without further continuation in later egg passages. The large number of SNPs has shown 
the viral population as a constantly active genomic environment in nucleocapsid and spike 
encoding regions possibly responsible for the process of attenuation. The observed 
situation has shown that SNPs and their accumulation in viral genome might be due to 
random selection with no correlation to SNP clusters or absence of immune pressure in 
chicken eggs (Dolz et al., 2008 and Feng et al., 2015). 
 
4.10    The SNPs activity due to varying SNP frequency in ep110 
 
 The analysis of sequence data has shown a very little correlation between changes in the 
SNP frequency of ep110 and SNP accumulation in Sanger sequenced egg passages. 
However, the visible process of SNP accumulation can be detected as minor SNPs in early 
egg passages and consensus sequence SNPs in later egg passages of the viral populations. 
In addition, further investigation identified nucleotide positions where SNP appearance 
was detected in most of the egg passages screened by regular Sanger sequencing showing 
that number of SNPs in quasispecies increased over time. However, there is evidence for 
SNP appearance directly at consensus sequence level in early egg passages which seems to 
be continued in the viral population of later egg passages. Furthermore, the high SNP 
frequency in ep110 showed a similar trend of SNP accumulation but only in later egg 
passages presented by rapid accumulation in quasispecies. These data proved that high 
SNP frequency has only a partial influence on SNP appearance within the viral population. 
There is no visible pattern which could be identified as a logical explanation of SNP 
accumulation in Sanger sequenced egg passages relating to >80 % SNP frequency (ep110). 
This same observation was identified with the <80 % SNP frequency in ep110 showing 
minor SNP or SNPs at consensus sequence level and its different stages of accumulation in 
previous egg passages. However, the majority of SNPs identified in different egg passages 
depends mostly on the selection of minor SNPs driven by other factors responsible for viral 
attenuation. Furthermore, a reduced SNP frequency (<20 %) has also shown a decreasing 
number of detected SNPs across the viral population. In addition, further investigation 
could not find a correlation in SNP accumulation within egg passages relating to the 
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random SNPs with a low frequency (<20 %) in ep110. However, these Sanger sequence 
data presented SNPs which appeared more than once during the egg passages suggesting 
that low percentage of SNP frequency does not play a key role in selection of SNPs in viral 
population. In addition, the SNP activities in viral genome cannot be defined as predicable 
events and similar to random SNPs; it is impossible to make a prediction of SNP 
appearance. Furthermore, the analysis of sequenced data clearly showed that a relatively 
high (>50 %) SNP frequency has an increased influence on SNP accumulation in previous 
egg passages comparing to low (>20 %) frequency in ep110. However, this tendency 
cannot be used for investigation of exact SNP appearance relating to regular Sanger 
sequenced data of previous egg passages.  
 
4.11    Conclusion 
 
 The analyses of 454 pyrosequencing data obtained from ep4 and ep110 was used as a 
preliminary map of attenuation for one virulent strain of IBV. The generated a deep 
sequence data  but also Sanger sequencing outcomes from previous egg passages showed 
viral populations with dynamic SNPs across the viral genome. Interestingly, further 
analyses of Sanger sequenced data present a substantial number of SNP clusters and 
independent SNPs previously not identified in ep110 of A, A1, C and D isolates. In 
addition, the high activity in viral genomes identified in previous egg passages of spike and 
nucleocapsid encoding regions might have an impact on SNP appearance in pyrosequenced 
ep110s. Therefore, the multiple ways of SNP formation and their accumulation among egg 
passages were analysed as the potential reason of attenuation. Interestingly, only a fraction 
of identified SNPs were continued as polymorphisms in previous egg passages. In addition, 
those genomic mutations identified as independent SNP and/or SNP clusters in regular 
Sanger sequenced data were not found in ep110 deep sequenced data. Furthermore, the 454 
pyrosequencing dataset has shown the limited number of SNPs relating to frequency 
greater than 50 % in each egg isolate. In addition, the large number of SNP clusters and 
also the independent SNPs in Sanger sequenced data might have an influence on further 
changes in the viral genome defined with deep sequence data. Interestingly, dynamics in 
previous egg passages were observed within all egg isolates but only as few as nine SNPs 
with >50 % frequency might be a trigger for viral attenuation. However, the process of 
SNP accumulation in previous egg passages and its influence on SNP appearance in 
pyrosequenced ep110 is unknown. The genomic changes in early egg passages and its 
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continuation in later egg passages might have no connection with the SNPs identified with 
various frequencies in ep110. Definitely, the common SNPs with >50% frequency (ep110) 
identified in nucleocapsid and spike encoding region of more than one egg isolate can be 
classified as potential candidates playing a key role in attenuation process and should be 
considered as crucial in universal vaccine development after further testing. Therefore, the 
conclusion clearly states that only a few SNPs in viral genome might be responsible for 
attenuation process but the forces responsible for the degree of SNP accumulation and its 
number is still the point of the discussion.  
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Appendices 
Appendix 1. The details of primers used in amplification of IBV genome regions with the 
highest number of identified SNPs. The GC % content varies from 40-60 % within 18-
24nucletides. The annealing temperature varies from 50 oC in the case of primers for S2 
subunit (part 1) to 68 oC for S2 subunit (part 2) primers. 
Amplicon Primer name Annealing temp 
(oC) 
Sequence 5` to 3` 
S1 subunit S1_forward 57 TGAAAACTGAACAAAAGACAGA 
S1 subunit S1_reverse 57 GGGCAATTTGCAACATTTTCAG 
S2 subunit part1 S2(p1)_forward 50 ATGGTTTGCTTGTGTTGCCTCCC 
S2 subunit part1 S2(p1)_reverse 50 TTCCAGGAGCTAAGGGTACAGCC 
S2 subunit part2 S2(p2)_forward 68 ATGGTTTGCTTGTGTTGCCT 
S2 subunit part2 S2(p2)_reverse 68 AGGAAGGACGTGGGACTTTG 
Nucleocapsid N_forward 57 CCAGGGGAAAACTTGTGAGG 
Nucleocapsid N_reverse 57 TACCGTTCGTTTCCAGGCTA 
 
 
Appendix 2. The best optimum annealing temperature for 2nd set of primers for successful 
amplification of S1 subunit. 1 % agarose gel was used. Titles from left to right for gel 
image: 1kb plus ladder (M), 54 oC, 57 oC, 60 oC, 63 oC and negative control (NC, water). 
Approximate base pair size of product is shown on the left. 
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Appendix 3. The gel image S2 subunit part1 amplification.  1 % agarose gel was used.  
Blot A = 1st set of primers; Blot B 2nd set of primers. Titles from left to right in gel image: 
1 kB plus ladder, 46 oC, 48 oC, 50 oC, 52 oC and four negative controls (NC, water). 
Approximate base pair size of product is shown on the left. 
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Appendix 4. The results of investigation the best optimum annealing temperature for S2 
subunits (part 2). 1 % agarose gel was used. Titles from left to right in gel image: 1kb plus 
ladder (M), 50 oC, 52 oC, 54 oC, 58 oC, 60 oC, 62 oC, 64 oC, 66 oC, 68 oC, 70 oC and three 
negative controls (NC, water). Approximate base pair size of product is shown on the left. 
Blot A = 1st set of primers; Blot B = 2nd set of primers. 
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Appendix 5. The agarose gel image showing the nucleocapsid amplification with two set 
of primers. 1 % agarose gel was used to investigate the best optimum annealing 
temperature. Blot A = 1st set of primers; Blot B = 2nd set of primers. Titles from left to right 
in gel image: 1kb plus ladder (M), 51 oC, 54 oC, 57 oC, 60 oC and four negative controls 
(NC, water). Approximate base pair size of product is shown on the left. 
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Appendix 6. The agarose gel image of S1subnit amplification with 2nd set of primers. 1 % 
agarose gel with the best optimum annealing temperature at 57 oC. M = 1kb plus ladder 
(approximate product size in bp are indicated). Blot A = A and A1 isolate; Blot B= C and 
D isolate. A and B blots including egg passages (ep10-100) for each egg isolate. NC= 
negative control (water). 
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Appendix 7. The agarose gel image of S2 subunit (part 1) amplification with 2nd set of 
primers. 1 % agarose gel with the best optimum annealing temperature at 50 oC. M = base 
pair size marker (approximate product size in bp are indicated). Blot A = A isolate and part 
of A1; Blot B = A1 and C isolate; Blot C = D isolate. Blots A, B and C including egg 
passages (ep10-100) for each egg isolate. PC = positive control (Vaccinia virus); NC = 
negative control. 
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Appendix8.  The agarose gel image of Nucleocapsid amplification. 1 % agarose gel with 
the best optimum annealing temperature at 60 oC. M = base pair size marker (approximate 
product size in bp are indicated). Blot A = 1st set of primers (A isolate); Blot B = 2nd set of 
primers (A isolate), Blot C = 1st set of primers (A and A1 isolate), Blot D = 1st set of 
primers (A1 and C isolate) and Blot E = 1st set of primers (D isolate). Blots A-E including 
egg passages for all investigated isolates.  PC = positive control (Vaccinia virus); NC = 
negative control (water).  
116 
 
 
Appendix 9. The NanodropTM measurements of RNA samples extracted from egg 
passages. The “n/a” written in red colour presents samples excluded from measurements. 
A isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
1 10 2.8 1.58 0.01 
2 20 3.4 1.78 0.03 
3 30 7.7 1.65 0.27 
4 40 4.5 1.41 0.14 
5 50 5.3 1.91 0.03 
6 60 3.0 2.01 0.03 
7 70 5.3 1.89 0.11 
8 80 7.2 1.80 0.04 
9 90 3.5 2.18 0.02 
10 100 5.8 2.01 0.04 
A1 isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
11 10 n/a n/a n/a 
12 20 6.9 1.82 0.08 
13 30 4.2 1.81 0.10 
14 40 3.7 2.06 0.06 
15 50 4.7 1.83 0.03 
16 60 5.7 1.87 0.05 
17 70 3.1 2.04 0.04 
18 80 7.6 1.87 0.09 
19 90 2.1 2.69 0.03 
20 100 1.2 3.42 0.01 
C isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
21 10 4.8 2.17 0.03 
22 20 3.7 1.73 0.04 
23 30 3.5 1.91 0.11 
24 40 4.1 1.83 0.64 
25 50 4.2 1.62 0.03 
26 60 4.7 1.45 0.01 
27 70 3.1 1.82 0.06 
28 80 6.5 1.66 0.07 
29 90 2.3 1.75 0.05 
30 100 1.5 2.36 0.02 
D isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
31 10 4.3 1.87 0.03 
32 20 6.0 1.81 0.07 
33 30 5.1 1.68 0.08 
34 40 5.7 1.82 0.07 
35 50 9.9 1.98 0.11 
36 60 4.3 1.88 0.01 
37 70 4.7 1.76 0.08 
38 80 7.4 1.75 0.12 
39 90 7.8 1.87 0.05 
40 100 2.5 2.72 0.04 
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Appendix 10.  NanodropTM readings of the amplification process (S1 subunit -2nd set of 
primers). The “n/a” written in red colour presents samples excluded from measurements. 
A isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
1 10 30.9 1.82 0.26 
2 20 58.7 1.75 1.57 
3 30 53.9 1.73 1.36 
4 40 78.2 1.72 1.34 
5 50 66.1 1.73 1.37 
6 60 33.5 1.62 0.76 
7 70 22.4 1.61 0.67 
8 80 41 1.80 0.33 
9 90 32.9 1.62 0.89 
10 100 37.7 2.11 0.04 
A1 isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
11 10 n/a n/a n/a 
12 20 20.5 1.58 0.96 
13 30 21.2 1.59 0.74 
14 40 23 1.73 0.99 
15 50 26.2 1.6 0.82 
16 60 36.4 1.66 0.99 
17 70 30.3 1.65 0.82 
18 80 16.9 1.75 1.21 
19 90 19.4 1.71 1.13 
20 100 23.6 1.58 0.92 
C isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
21 10 26.7 1.66 0.81 
22 20 27.8 1.63 0.98 
23 30 61.6 1.69 1.06 
24 40 32.3 1.68 1.13 
25 50 18.8 1.78 1.16 
26 60 21.3 1.74 1.25 
27 70 34.7 1.71 1.37 
28 80 44.1 1.81 1.72 
29 90 36.7 1.61 0.71 
30 100 21.5 1.62 0.88 
D isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
31 10 17.6 1.75 1.49 
32 20 49.7 1.74 1.25 
33 30 68.4 1.79 1.50 
34 40 61.4 1.84 1.91 
35 50 63.4 1.78 1.52 
36 60 45.3 1.75 1.35 
37 70 86.5 1.72 1.26 
38 80 67.1 1.82 1.86 
39 90 76.1 1.73 1.38 
40 100 80.1 1.74 1.36 
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Appendix 11.  The summary of S2 subunit (part1) DNA concentration – 2nd set of primers 
by NanodropTM measurement. The “n/a” written in red colour presents samples excluded 
from measurements. 
A isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
1 10 36.4 1.92 1.42 
2 20 50.4 1.85 0.43 
3 30 36.1 1.83 1.11 
4 40 28.5 1.82 0.56 
5 50 29.9 1.79 0.97 
6 60 36.4 1.84 1.43 
7 70 31.1 1.84 1.12 
8 80 42.5 1.84 1.51 
9 90 36.3 1.91 1.33 
10 100 39.8 1.86 0.84 
A1 isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
11 10 n/a n/a n/a 
12 20 8.9 2.27 0.05 
13 30 30.8 1.84 0.33 
14 40 39.5 1.87 0.18 
15 50 43.5 1.90 0.40 
16 60 23.9 1.78 0.16 
17 70 12.2 2.14 0.11 
18 80 9.8 1.64 0.06 
19 90 11.2 1.96 0.01 
20 100 28 2.17 0.03 
C isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
21 10 25.3 1.96 0.03 
22 20 20.9 1.85 0.16 
23 30 37.2 1.79 0.15 
24 40 17.1 1.91 0.06 
25 50 37.1 1.83 0.08 
26 60 19.9 1.89 0.08 
27 70 25.9 1.98 0.09 
28 80 16.8 1.79 0.12 
29 90 15.8 1.96 0.04 
30 100 9.6 2.01 0.03 
D isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
31 10 n/a n/a n/a 
32 20 28 1.99 0.07 
33 30 31.4 1.93 0.28 
34 40 31.8 1.96 0.06 
35 50 39.9 3.31 0.26 
36 60 25.5 2.31 0.03 
37 70 22.8 1.95 0.42 
38 80 17.6 2.02 0.25 
39 90 16.5 2.10 0.14 
40 100 29.9 1.97 0.09 
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Appendix 12. The summary from NanodropTM readings of nucleocapsid DNA 
concentration after amplification process. The “n/a” written in red colour presents samples 
not included in measurement. 
A isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
1 10 20.8 2 0.07 
2 20 24.8 2.15 0.05 
3 30 39.2 1.94 0.15 
4 40 31.9 1.82 0.17 
5 50 30 1.80 0.10 
6 60 25.3 1.89 0.12 
7 70 31.5 1.84 0.23 
8 80 31.6 1.91 0.15 
9 90 29.4 2.10 0.05 
10 100 21.4 1.87 0.11 
A1 isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
11 10 n/a n/a n/a 
12 20 15.7 2.65 0.02 
13 30 28.7 1.91 0.18 
14 40 45.7 1.91 0.15 
15 50 40.3 1.93 0.13 
16 60 36.8 1.96 0.14 
17 70 39.8 1.96 0.17 
18 80 29.5 2.02 0.09 
19 90 40.2 1.93 0.08 
20 100 18.8 2.13 0.05 
C isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
21 10 17.9 2.06 0.04 
22 20 13.7 2.29 0.02 
23 30 28.4 2.01 0.05 
24 40 18.3 2.15 0.02 
25 50 16.1 2.13 0.02 
26 60 20.5 2.18 0.03 
27 70 28.6 1.96 0.03 
28 80 24.6 2.22 0.03 
29 90 21.1 2.09 0.03 
30 100 22.3 1.80 0.05 
D isolate 
Sample # Egg passage # Concentration  (ng/µl) 260/280 ratio 260/230 ratio 
31 10 n/a n/a n/a 
32 20 18.2 1.6 0.53 
33 30 27 1.6 0.83 
34 40 29.6 1.71 0.69 
35 50 20.5 1.69 0.13 
36 60 22.2 1.6 0.73 
37 70 29.9 1.65 0.84 
38 80 26.7 1.66 0.79 
39 90 21.7 1.77 0.08 
40 100 19.9 1.72 0.58 
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C isolate 
Nucleotide # ep4 ep10 ep20 ep30 ep40 ep50 ep60 ep70 ep80 ep90 ep100 
25969 G         R  
25970 T         K  
26039 T      C     
26045 C      T     
26048 A W          
26049 G      C     
26051 A      C M    
26052 G    T       
26053 T       Y    
26056 G      T     
26057 C      T     
26058 T       W    
26060 C W          
26061 A       Y    
26062 C W     T     
26066 C       S    
26067 G      T     
26068 C      T     
26069 C      G     
26077 G R          
26081 G    T  W     
26082 T      C R    
26083 A      C   M  
26088 T    A       
26089 NIL T          
26091 T W          
26092 C      G     
26096 A      W     
26100 A    T  T     
26101 G      A    R 
26102 A      G     
26103 A      G     
26104 A      G     
26105 A    T       
26106 A    C       
26107 T       K    
26108 C    G       
26118 G           
26122 G       T    
26123 C           
26124 A       C    
26125 G       C    
26132 T       G    
26133 A C          
26137 G T          
26145 A       T    
26146 A       T    
26147 G       A    
26149 T       C    
26150 A       T    
26151 G       K    
26156 A           
26156 A       C    
26158 G C      T    
26159 C       G    
26164 T       G    
26167 A       T    
26170 T        G   
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26172 G T        T  
26173 A         T  
26177 A C W         
26179 C A A A     A A  
26180 C         T  
26181 C T        A  
26182 A T          
26183 A        C   
26184 T C  A      C  
26185 T        A A  
26188 A   T      T  
26189 G         C  
26191 A        C   
26193 A   T        
26194 T        G   
26195 T   A      G  
26198 T   C     G   
26200 T  A         
26211 A  T         
26227 C  T         
26238 A  C         
26239 A  C         
26285 C          Y 
26365 G          A 
26376 NIL          G 
26513 NIL          T 
26517 G  T         
26526 G  A         
26537 T  C         
26549 G  A         
26568 A  C         
26573 G  A         
26586 G  A         
26603 G  A         
26609 C  G         
26610 A  G         
26677 G   A        
26683 A        T   
26687 T        G   
26691 G        A   
26693 T        G   
26699 G        A   
26700 A        G   
26701 T        A   
26718 NIL        T   
26720 A        G   
26725 G       C    
26727 C       G    
26730 G       T    
26732 T       G    
26737 G A          
26738 A       G    
26740 T       A    
26742 C       G    
26747 C       A    
26748 C       A    
26750 A       G    
26754 A  W     T    
26755 C       T    
26762 G         A  
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26765 T       G    
26766 G       C    
26767 C       G    
26768 T       G    
26773 T       A    
26774 C   M        
26784 T W          
26804 A       G    
26807 A       G    
26810 T       A    
26822 A    C       
26823 NIL    A       
26857 C         M  
26879 A  W         
 
Appendix 13. The table below presents the polymorphism in a form of independent SNPs 
and SNP clusters found as additional SNPs in the nucleocapsid encoding region of C 
isolate. Orange = minor SNP, red = lack of SNP and green = SNP at consensus sequence 
level. 
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Appendix 14. The table used for identification minor SNPs found within egg passages 
using regular Sanger sequencing method. 
IUPAC Code Meaning IUPAC Code Meaning 
A A Y C or T 
C C K G or T 
G G V A or C or G 
T T H A or C or T 
M A or C D A or G or T 
R A or G B C or G or T 
W A or T N G or A or T or C 
S C or G - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
124 
 
 
Glossary 
 
Consensus sequence SNP or SNP at consensus sequence level – defined nucleotide 
change observed at investigated genome position in sequence alignment with >50 % SNP 
frequency. 
Early egg passages – term used to describe the SNP investigation in Sanger sequenced 
data from ep10 to ep50. 
Later egg passages – the egg passages from ep60 to ep100 screened with Sanger 
sequencing. 
Minor SNP – the occurrence of more than one different nucleotide molecules at this same 
genomic position relating to genome of viral population with <50 % SNP frequency. 
SNP cluster – the group of a minimum three SNPs within the IBV genome which are close 
to each other (<50 bp) and separated by the gap of 100 bp from the nearest SNP 
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